UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended SEPTEMBER 30, 2010
Commission File Number: 1-3433
THE DOW CHEMICAL COMPANY
(Exact name of registrant as specified in its charter)
Delaware | 38-1285128 | |
(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification No.) |
2030 DOW CENTER, MIDLAND, MICHIGAN 48674
(Address of principal executive offices) (Zip Code)
989-636-1000
(Registrants telephone number, including area code)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. þ Yes ¨ No
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). þ Yes ¨ No
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of large accelerated filer, accelerated filer and smaller reporting company in Rule 12b-2 of the Exchange Act.
Large accelerated filer | þ | Accelerated filer | ¨ | |||||
Non-accelerated filer | ¨ | Smaller reporting company | ¨ |
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). ¨ Yes þ No
Class | Outstanding at September 30, 2010 | |
Common Stock, par value $2.50 per share | 1,160,715,964 shares |
QUARTERLY REPORT ON FORM 10-Q
For the quarterly period ended September 30, 2010
TABLE OF CONTENTS
PAGE | ||||||||
Item 1. |
3 | |||||||
3 | ||||||||
4 | ||||||||
5 | ||||||||
6 | ||||||||
7 | ||||||||
8 | ||||||||
Item 2. |
Managements Discussion and Analysis of Financial Condition and Results of Operations. |
49 | ||||||
49 | ||||||||
50 | ||||||||
69 | ||||||||
72 | ||||||||
Item 3. |
76 | |||||||
Item 4. |
77 | |||||||
Item 1. |
78 | |||||||
Item 1A. |
78 | |||||||
Item 2. |
Unregistered Sales of Equity Securities and Use of Proceeds. |
78 | ||||||
Item 6. |
78 | |||||||
80 | ||||||||
81 |
2
PART I - FINANCIAL INFORMATION
The Dow Chemical Company and Subsidiaries
Consolidated Statements of Income
Three Months Ended
|
Nine Months Ended
|
|||||||||||||||
In millions, except per share amounts (Unaudited) | Sept. 30,
2010 |
Sept. 30,
2009 |
Sept. 30,
2010 |
Sept. 30,
2009 |
||||||||||||
Net Sales |
$ | 12,868 | $ | 12,046 | $ | 39,903 | $ | 32,409 | ||||||||
Cost of sales |
10,841 | 10,386 | 33,962 | 28,288 | ||||||||||||
Research and development expenses |
403 | 400 | 1,217 | 1,073 | ||||||||||||
Selling, general and administrative expenses |
640 | 683 | 1,950 | 1,789 | ||||||||||||
Amortization of intangibles |
124 | 108 | 377 | 242 | ||||||||||||
Restructuring charges |
- | - | 29 | 681 | ||||||||||||
Acquisition and integration related expenses |
35 | 21 | 98 | 121 | ||||||||||||
Equity in earnings of nonconsolidated affiliates |
251 | 224 | 799 | 411 | ||||||||||||
Sundry income (expense) - net |
(10 | ) | 813 | 168 | 833 | |||||||||||
Interest income |
7 | 6 | 24 | 27 | ||||||||||||
Interest expense and amortization of debt discount |
362 | 488 | 1,105 | 1,167 | ||||||||||||
Income from Continuing Operations Before Income Taxes |
711 | 1,003 | 2,156 | 319 | ||||||||||||
Provision (Credit) for income taxes |
114 | 204 | 348 | (69 | ) | |||||||||||
Net Income from Continuing Operations |
597 | 799 | 1,808 | 388 | ||||||||||||
Income (Loss) from discontinued operations, net of income taxes |
- | (4 | ) | - | 110 | |||||||||||
Net Income |
597 | 795 | 1,808 | 498 | ||||||||||||
Net income (loss) attributable to noncontrolling interests |
- | (1 | ) | 9 | 22 | |||||||||||
Net Income Attributable to The Dow Chemical Company |
597 | 796 | 1,799 | 476 | ||||||||||||
Preferred stock dividends |
85 | 85 | 255 | 227 | ||||||||||||
Net Income Available for The Dow Chemical Company Common Stockholders |
$ | 512 | $ | 711 | $ | 1,544 | $ | 249 | ||||||||
Per Common Share Data: |
||||||||||||||||
Net income from continuing operations available for common stockholders |
$ | 0.45 | $ | 0.65 | $ | 1.37 | $ | 0.13 | ||||||||
Discontinued operations attributable to common stockholders |
- | (0.01 | ) | - | 0.11 | |||||||||||
Earnings per common share - basic |
$ | 0.45 | $ | 0.64 | $ | 1.37 | $ | 0.24 | ||||||||
Net income from continuing operations available for common stockholders |
$ | 0.45 | $ | 0.64 | $ | 1.35 | $ | 0.13 | ||||||||
Discontinued operations attributable to common stockholders |
- | (0.01 | ) | - | 0.11 | |||||||||||
Earnings per common share - diluted |
$ | 0.45 | $ | 0.63 | $ | 1.35 | $ | 0.24 | ||||||||
Common stock dividends declared per share of common stock |
$ | 0.15 | $ | 0.15 | $ | 0.45 | $ | 0.45 | ||||||||
Weighted-average common shares outstanding - basic |
1,128.0 | 1,108.4 | 1,123.6 | 1,020.0 | ||||||||||||
Weighted-average common shares outstanding - diluted |
1,145.5 | 1,120.7 | 1,140.7 | 1,029.4 | ||||||||||||
Depreciation |
$ | 555 | $ | 601 | $ | 1,717 | $ | 1,680 | ||||||||
Capital Expenditures |
$ | 497 | $ | 266 | $ | 1,188 | $ | 825 |
See Notes to the Consolidated Financial Statements.
3
The Dow Chemical Company and Subsidiaries
Consolidated Balance Sheets In millions (Unaudited) |
Sept. 30,
2010 |
Dec. 31,
2009 |
||||||||
Assets |
||||||||||
Current Assets |
||||||||||
Cash and cash equivalents (variable interest entities restricted - 2010: $101) |
$ | 3,223 | $ | 2,846 | ||||||
Marketable securities and interest-bearing deposits |
4 | - | ||||||||
Accounts and notes receivable: |
||||||||||
Trade (net of allowance for doubtful receivables - 2010: $136; 2009: $160) |
4,899 | 5,656 | ||||||||
Other |
4,675 | 3,539 | ||||||||
Inventories |
7,283 | 6,847 | ||||||||
Deferred income tax assets - current |
585 | 654 | ||||||||
Total current assets |
20,669 | 19,542 | ||||||||
Investments |
||||||||||
Investment in nonconsolidated affiliates |
3,271 | 3,224 | ||||||||
Other investments (investments carried at fair value - 2010: $2,175; 2009: $2,136) |
2,625 | 2,561 | ||||||||
Noncurrent receivables |
343 | 210 | ||||||||
Total investments |
6,239 | 5,995 | ||||||||
Property |
||||||||||
Property |
51,025 | 53,567 | ||||||||
Accumulated depreciation |
33,609 | 35,426 | ||||||||
Net property (variable interest entities restricted - 2010: $1,114) |
17,416 | 18,141 | ||||||||
Other Assets |
||||||||||
Goodwill |
13,000 | 13,213 | ||||||||
Other intangible assets (net of accumulated amortization - 2010: $1,654; 2009: $1,302) |
5,625 | 5,966 | ||||||||
Deferred income tax assets - noncurrent |
1,866 | 2,039 | ||||||||
Asbestos-related insurance receivables - noncurrent |
250 | 330 | ||||||||
Deferred charges and other assets |
936 | 792 | ||||||||
Total other assets |
21,677 | 22,340 | ||||||||
Total Assets |
$ | 66,001 | $ | 66,018 | ||||||
Liabilities and Equity |
||||||||||
Current Liabilities |
||||||||||
Notes payable |
$ | 1,329 | $ | 2,139 | ||||||
Long-term debt due within one year |
1,772 | 1,082 | ||||||||
Accounts payable: |
||||||||||
Trade |
3,978 | 4,153 | ||||||||
Other |
2,025 | 2,014 | ||||||||
Income taxes payable |
291 | 176 | ||||||||
Deferred income tax liabilities - current |
98 | 78 | ||||||||
Dividends payable |
256 | 254 | ||||||||
Accrued and other current liabilities |
3,410 | 3,209 | ||||||||
Total current liabilities |
13,159 | 13,105 | ||||||||
Long-Term Debt |
18,030 | 19,152 | ||||||||
Other Noncurrent Liabilities |
||||||||||
Deferred income tax liabilities - noncurrent |
1,301 | 1,367 | ||||||||
Pension and other postretirement benefits - noncurrent |
7,299 | 7,242 | ||||||||
Asbestos-related liabilities - noncurrent |
735 | 734 | ||||||||
Other noncurrent obligations |
2,873 | 3,294 | ||||||||
Total other noncurrent liabilities |
12,208 | 12,637 | ||||||||
Stockholders Equity |
||||||||||
Preferred stock, series A ($1.00 par, $1,000 liquidation preference, 4,000,000 shares) |
4,000 | 4,000 | ||||||||
Common stock |
2,919 | 2,906 | ||||||||
Additional paid-in capital |
2,116 | 1,913 | ||||||||
Retained earnings |
17,478 | 16,704 | ||||||||
Accumulated other comprehensive loss |
(3,810 | ) | (3,892) | |||||||
Unearned ESOP shares |
(484 | ) | (519) | |||||||
Treasury stock at cost |
(313 | ) | (557) | |||||||
The Dow Chemical Companys stockholders equity |
21,906 | 20,555 | ||||||||
Noncontrolling interests |
698 | 569 | ||||||||
Total equity |
22,604 | 21,124 | ||||||||
Total Liabilities and Equity |
$ | 66,001 | $ | 66,018 |
See Notes to the Consolidated Financial Statements.
4
The Dow Chemical Company and Subsidiaries
Consolidated Statements of Cash Flows
Nine Months Ended | ||||||||||
In millions (Unaudited) | Sept. 30, 2010 |
Sept. 30, 2009 |
||||||||
Operating Activities |
||||||||||
Net Income |
$ | 1,808 | $ | 498 | ||||||
Adjustments to reconcile net income to net cash provided by operating activities: |
||||||||||
Depreciation and amortization |
2,207 | 2,023 | ||||||||
Provision (Credit) for deferred income tax |
32 | (520) | ||||||||
Earnings of nonconsolidated affiliates less than (in excess of) dividends received |
(241 | ) | 260 | |||||||
Pension contributions |
(177 | ) | (201) | |||||||
Net loss (gain) on sales of investments |
1 | (66) | ||||||||
Net loss (gain) on sales of property, businesses and consolidated companies |
52 | (189) | ||||||||
Other net gain |
(16 | ) | (2) | |||||||
Net gain on sales of ownership interest in nonconsolidated affiliates |
(25 | ) | (785) | |||||||
Restructuring charges |
29 | 676 | ||||||||
Excess tax benefits from share-based payment arrangements |
(3 | ) | - | |||||||
Changes in assets and liabilities, net of effects of acquired and divested companies: |
||||||||||
Accounts and notes receivable |
(1,539 | ) | (1,277) | |||||||
Proceeds from interests in trade accounts receivable conduits |
818 | - | ||||||||
Inventories |
(946 | ) | (60) | |||||||
Accounts payable |
(139 | ) | (178) | |||||||
Other assets and liabilities |
406 | 492 | ||||||||
Cash provided by operating activities |
2,267 | 671 | ||||||||
Investing Activities |
||||||||||
Capital expenditures |
(1,188 | ) | (825) | |||||||
Proceeds from sales of property, businesses and consolidated companies |
1,716 | 278 | ||||||||
Acquisitions of businesses |
(7 | ) | - | |||||||
Purchases of previously leased assets |
(45 | ) | (713) | |||||||
Investments in consolidated companies, net of cash acquired |
(167 | ) | (14,838) | |||||||
Investments in nonconsolidated affiliates |
(101 | ) | (115) | |||||||
Distributions from nonconsolidated affiliates |
24 | 7 | ||||||||
Proceeds from sales of nonconsolidated affiliates |
113 | 1,403 | ||||||||
Purchase of unallocated Rohm and Haas ESOP shares |
- | (552) | ||||||||
Purchases of investments |
(742 | ) | (300) | |||||||
Change in restricted cash |
436 | - | ||||||||
Proceeds from sales and maturities of investments |
742 | 440 | ||||||||
Cash provided by (used in) investing activities |
781 | (15,215) | ||||||||
Financing Activities |
||||||||||
Changes in short-term notes payable |
(740 | ) | (892) | |||||||
Proceeds from notes payable |
84 | - | ||||||||
Payments on notes payable |
(668 | ) | - | |||||||
Proceeds from revolving credit facility |
- | 3,000 | ||||||||
Payments on revolving credit facility |
- | (2,100) | ||||||||
Proceeds from Term Loan |
- | 9,226 | ||||||||
Payments on Term Loan |
- | (8,226) | ||||||||
Proceeds from issuance of long-term debt |
539 | 8,005 | ||||||||
Payments on long-term debt |
(1,374 | ) | (1,576) | |||||||
Redemption of preferred securities of subsidiaries and payment of accrued dividends |
- | (520) | ||||||||
Purchases of treasury stock |
(14 | ) | (5) | |||||||
Proceeds from issuance of common stock |
92 | 966 | ||||||||
Proceeds from issuance of preferred stock |
- | 7,000 | ||||||||
Proceeds from sales of common stock |
70 | 554 | ||||||||
Issuance costs for debt and equity securities |
- | (368) | ||||||||
Excess tax benefits from share-based payment arrangements |
3 | - | ||||||||
Distributions to noncontrolling interests |
(7 | ) | (24) | |||||||
Dividends paid to stockholders |
(760 | ) | (779) | |||||||
Cash provided by (used in) financing activities |
(2,775 | ) | 14,261 | |||||||
Effect of Exchange Rate Changes on Cash |
58 | 64 | ||||||||
Cash Assumed in Initial Consolidation of Variable Interest Entities |
46 | - | ||||||||
Summary |
||||||||||
Increase (decrease) in cash and cash equivalents |
377 | (219) | ||||||||
Cash and cash equivalents at beginning of year |
2,846 | 2,800 | ||||||||
Cash and cash equivalents at end of period |
$ | 3,223 | $ | 2,581 | ||||||
See Notes to the Consolidated Financial Statements.
5
The Dow Chemical Company and Subsidiaries
Consolidated Statements of Equity
Nine Months Ended | ||||||||||
In millions (Unaudited) |
Sept. 30, 2010 |
Sept. 30, 2009 |
||||||||
Preferred Stock |
||||||||||
Balance at beginning of year |
$ | 4,000 | - | |||||||
Preferred stock issued |
- | $ | 7,000 | |||||||
Preferred stock repurchased |
- | (2,500) | ||||||||
Preferred stock converted to common stock |
- | (500) | ||||||||
Balance at end of period |
4,000 | 4,000 | ||||||||
Common Stock |
||||||||||
Balance at beginning of year |
2,906 | $ | 2,453 | |||||||
Common stock issued |
13 | 453 | ||||||||
Balance at end of period |
2,919 | 2,906 | ||||||||
Additional Paid-in Capital |
||||||||||
Balance at beginning of year |
1,913 | 872 | ||||||||
Common stock issued |
79 | 2,643 | ||||||||
Sale of shares to ESOP |
- | (1,529) | ||||||||
Stock-based compensation and allocation of ESOP shares |
124 | 39 | ||||||||
Balance at end of period |
2,116 | 2,025 | ||||||||
Retained Earnings |
||||||||||
Balance at beginning of year |
16,704 | 17,013 | ||||||||
Net income available for The Dow Chemical Company common stockholders |
1,544 | 249 | ||||||||
Dividends declared on common stock (Per share: $0.45 in 2010, $0.45 in 2009) |
(507 | ) | (471) | |||||||
Other |
(15 | ) | (6) | |||||||
Impact of adoption of ASU 2009-17, net of tax |
(248 | ) | - | |||||||
Balance at end of period |
17,478 | 16,785 | ||||||||
Accumulated Other Comprehensive Income (Loss) |
||||||||||
Unrealized Gains (Losses) on Investments at beginning of year |
79 | (111) | ||||||||
Net change in unrealized gains (losses) |
35 | 158 | ||||||||
Balance at end of period |
114 | 47 | ||||||||
Cumulative Translation Adjustments at beginning of year |
624 | 221 | ||||||||
Translation adjustments |
(154 | ) | 331 | |||||||
Balance at end of period |
470 | 552 | ||||||||
Pension and Other Postretirement Benefit Plans at beginning of year |
(4,587 | ) | (4,251) | |||||||
Adjustments to pension and other postretirement benefit plans |
201 | 64 | ||||||||
Balance at end of period |
(4,386 | ) | (4,187) | |||||||
Accumulated Derivative Loss at beginning of year |
(8 | ) | (248) | |||||||
Net hedging results |
(15 | ) | (68) | |||||||
Reclassification to earnings |
15 | 291 | ||||||||
Balance at end of period |
(8 | ) | (25) | |||||||
Total accumulated other comprehensive loss |
(3,810 | ) | (3,613) | |||||||
Unearned ESOP Shares |
||||||||||
Balance at beginning of year |
(519 | ) | - | |||||||
Shares acquired |
(1 | ) | (553) | |||||||
Shares allocated to ESOP participants |
36 | 25 | ||||||||
Balance at end of period |
(484 | ) | (528) | |||||||
Treasury Stock |
||||||||||
Balance at beginning of year |
(557 | ) | (2,438) | |||||||
Purchases |
(14 | ) | (5) | |||||||
Sale of shares to ESOP |
- | 1,529 | ||||||||
Issuance to employees and employee plans |
258 | 68 | ||||||||
Balance at end of period |
(313 | ) | (846) | |||||||
The Dow Chemical Companys Stockholders Equity |
21,906 | 20,729 | ||||||||
Noncontrolling Interests |
||||||||||
Balance at beginning of year |
569 | 69 | ||||||||
Net income attributable to noncontrolling interests |
9 | 22 | ||||||||
Distributions to noncontrolling interests |
(7 | ) | (24) | |||||||
Acquisition of Rohm and Haas Company noncontrolling interests |
- | 432 | ||||||||
Impact of adoption of ASU 2009-17 |
100 | - | ||||||||
Other |
27 | 17 | ||||||||
Balance at end of period |
698 | 516 | ||||||||
Total Equity |
$ | 22,604 | $ | 21,245 | ||||||
See Notes to the Consolidated Financial Statements.
6
The Dow Chemical Company and Subsidiaries
Consolidated Statements of Comprehensive Income
Three Months Ended | Nine Months Ended | |||||||||||||||||
In millions (Unaudited) |
Sept. 30, 2010 |
Sept. 30, 2009 |
Sept. 30, 2010 |
Sept. 30, 2009 |
||||||||||||||
Net Income |
$ | 597 | $ | 795 | $ | 1,808 | $ | 498 | ||||||||||
Other Comprehensive Income, Net of Tax |
||||||||||||||||||
Net change in unrealized gains on investments |
54 | 107 | 35 | 158 | ||||||||||||||
Translation adjustments |
868 | 233 | (154 | ) | 331 | |||||||||||||
Adjustments to pension and other postretirement benefit plans |
52 | 25 | 201 | 64 | ||||||||||||||
Net gains (losses) on cash flow hedging derivative instruments | (4 | ) | 69 | - | 223 | |||||||||||||
Total other comprehensive income |
970 | 434 | 82 | 776 | ||||||||||||||
Comprehensive Income |
1,567 | 1,229 | 1,890 | 1,274 | ||||||||||||||
Comprehensive income (loss) attributable to noncontrolling interests, net of tax |
- | (1 | ) | 9 | 22 | |||||||||||||
Comprehensive Income Attributable to The Dow Chemical Company |
$ | 1,567 | $ | 1,230 | $ | 1,881 | $ | 1,252 | ||||||||||
See Notes to the Consolidated Financial Statements.
7
The Dow Chemical Company and Subsidiaries | ||
PART I FINANCIAL INFORMATION, Item 1. Financial Statements. | ||
(Unaudited) | Notes to the Consolidated Financial Statements |
Note |
Page | |||||
A | 8 | |||||
B | 8 | |||||
C | 9 | |||||
D | 11 | |||||
E | 12 | |||||
F | 14 | |||||
G | 14 | |||||
H | 16 | |||||
I | 24 | |||||
J | 26 | |||||
K | 33 | |||||
L | 35 | |||||
M | 37 | |||||
N | 37 | |||||
O | 38 | |||||
P | 39 | |||||
Q | 40 |
NOTE A CONSOLIDATED FINANCIAL STATEMENTS
The unaudited interim consolidated financial statements of The Dow Chemical Company and its subsidiaries (Dow or the Company) were prepared in accordance with accounting principles generally accepted in the United States of America (U.S. GAAP) and reflect all adjustments (including normal recurring accruals) which, in the opinion of management, are considered necessary for the fair presentation of the results for the periods presented. These statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the Companys Annual Report on Form 10-K for the year ended December 31, 2009.
Certain changes to prior year balance sheet amounts have been made in accordance with the accounting guidance for business combinations to reflect adjustments made during the measurement period to provisional amounts recorded for assets acquired and liabilities assumed from Rohm and Haas Company (Rohm and Haas) on April 1, 2009.
NOTE B RECENT ACCOUNTING GUIDANCE
Recently Adopted Accounting Guidance
On January 1, 2010, the Company adopted Accounting Standards Update (ASU) 2009-16, Transfers and Servicing (Topic 860): Accounting for Transfers of Financial Assets. This ASU is intended to improve the information provided in financial statements concerning transfers of financial assets, including the effects of transfers on financial position, financial performance and cash flows, and any continuing involvement of the transferor with the transferred financial assets. The Company evaluated the impact of adopting the guidance and the terms and conditions in place at January 1, 2010 and determined that certain sales of accounts receivable would be classified as secured borrowings. Under the Companys sale of accounts receivable arrangements, $915 million was outstanding at January 1, 2010. The maximum amount of receivables available for participation in these programs was $1,939 million at January 1, 2010. See Note K for additional information about transfers of financial assets.
On January 1, 2010, the Company adopted ASU 2009-17, Consolidations (Topic 810): Improvements to Financial Reporting by Enterprises Involved with Variable Interest Entities, which amended the consolidation guidance applicable to variable interest entities and required additional disclosures concerning an enterprises continuing involvement with variable interest entities. The Company evaluated the impact of this guidance and determined that the adoption resulted in the consolidation of two additional joint ventures, an owner trust and an entity that is used to monetize accounts receivable. At January 1, 2010, $793 million in assets (net of tax, including the impact on Investment in nonconsolidated affiliates), $941 million in liabilities, $100 million in noncontrolling interests and a cumulative effect adjustment to retained earnings of $248 million were recorded as a result of the adoption of this guidance. See Note L for additional information about variable interest entities.
8
On January 1, 2010, the Company adopted ASU 2010-06, Fair Value Measurements and Disclosures (Topic 820): Improving Disclosures about Fair Value Measurements, which added disclosure requirements about transfers in and out of Levels 1 and 2 and separate disclosures about activity relating to Level 3 measurements and clarifies existing disclosure requirements related to the level of disaggregation and input and valuation techniques. See Note I for additional disclosures about fair value measurements.
Accounting Guidance Issued But Not Adopted as of September 30, 2010
In October 2009, the Financial Accounting Standards Board issued ASU 2009-13, Revenue Recognition (Topic 605): Multiple-Deliverable Revenue Arrangements a consensus of the FASB Emerging Issues Task Force, which amends the criteria for when to evaluate individual delivered items in a multiple deliverable arrangement and how to allocate consideration received. This ASU is effective for fiscal years beginning on or after June 15, 2010, which is January 1, 2011 for the Company. The Company is currently evaluating the impact of adopting the guidance.
2009 Restructuring
On June 30, 2009, the Companys Board of Directors approved a restructuring plan related to the Companys acquisition of Rohm and Haas as well as actions to advance the Companys strategy and to respond to continued weakness in the global economy. The restructuring plan included the elimination of approximately 2,500 positions primarily resulting from synergies to be achieved as a result of the acquisition of Rohm and Haas. In addition, the Company will shut down a number of manufacturing facilities. These actions are expected to be completed primarily by the end of 2011. As a result of the restructuring activities, the Company recorded pretax restructuring charges of $677 million in the second quarter of 2009, consisting of asset write-downs and write-offs of $454 million, costs associated with exit or disposal activities of $68 million and severance costs of $155 million. The impact of the charges was shown as Restructuring charges in the consolidated statements of income.
The severance component of the 2009 restructuring charges of $155 million was for the separation of approximately 2,500 employees under the terms of the Companys ongoing benefit arrangements, primarily over two years. At December 31, 2009, severance of $72 million had been paid and a currency adjusted liability of $84 million remained for approximately 1,221 employees. In the nine-month period ended September 30, 2010, severance of $69 million was paid, leaving a currency adjusted liability of $14 million for approximately 313 employees at September 30, 2010.
In the first quarter of 2010, the Company recorded an additional $8 million charge to adjust the impairment of long-lived assets and other assets related to the divestiture of certain acrylic monomer and specialty latex assets completed in the first quarter of 2010, and an additional $8 million charge related to the shutdown of a small manufacturing facility under the 2009 restructuring plan. The impact of these charges is shown as Restructuring charges in the consolidated statements of income and was reflected in the following operating segments: Electronic and Specialty Materials ($8 million), Coatings and Infrastructure ($5 million) and Performance Products ($3 million).
In the second quarter of 2010, the Company recorded additional restructuring charges of $13 million, which included the write-off of other assets of $5 million, additional costs associated with exit or disposal activities of $7 million and additional severance of $1 million related to the divestiture of certain acrylic monomer assets and the hollow sphere particle business that was included in the 2009 restructuring plan. The impact of these charges is shown as Restructuring charges in the consolidated statements of income and was reflected in Performance Products ($12 million) and Corporate ($1 million).
9
The following table summarizes the 2010 activities related to the Companys 2009 restructuring reserve:
2010 Activities Related to 2009 Restructuring In millions |
Impairment of Long-Lived Assets and Other Assets |
Costs associated with Exit or Disposal Activities |
Severance Costs |
Total | ||||||||||||
Reserve balance at December 31, 2009 |
- | $ 68 | $ 84 | $152 | ||||||||||||
Adjustment to reserve |
$ 21 | 7 | 1 | 29 | ||||||||||||
Cash payments |
- | - | (69 | ) | (69) | |||||||||||
Charges against reserve |
(21 | ) | (7 | ) | - | (28) | ||||||||||
Foreign currency impact |
- | - | (2 | ) | (2) | |||||||||||
Reserve balance at September 30, 2010 |
- | $ 68 | $ 14 | $82 |
Restructuring Reserve Assumed from Rohm and Haas
Included in liabilities assumed in the April 1, 2009 acquisition of Rohm and Haas was a reserve of $122 million for severance and employee benefits for the separation of 1,255 employees under the terms of Rohm and Haas ongoing benefit arrangement. The separations resulted from plant shutdowns, production schedule adjustments, productivity improvements and reductions in support services. Cash payments are expected to be paid primarily by the end of 2011. At December 31, 2009, a currency adjusted liability of $68 million remained for approximately 552 employees.
In the second quarter of 2010, the Company decreased the restructuring reserve $10 million due to the divestiture of the Powder Coatings business and to adjust the reserve to expected future severance payments. In the third quarter of 2010, the Company decreased the restructuring reserve $10 million to adjust the reserve to expected future severance payments. The impact of these adjustments is shown as Cost of sales in the consolidated statements of income and was reflected in Corporate. In the nine-month period ended September 30, 2010, severance of $21 million was paid, leaving a currency adjusted liability of $30 million for approximately 139 employees at September 30, 2010.
Restructuring Reserve Assumed from Rohm and Haas | ||||
In millions | Severance Costs |
|||
Reserve balance at December 31, 2009 |
$ 68 | |||
Adjustment to reserve |
(20) | |||
Cash payments |
(21) | |||
Foreign currency impact |
3 | |||
Reserve balance at September 30, 2010 |
$ 30 |
2008 Restructuring
On December 5, 2008, the Companys Board of Directors approved a restructuring plan as part of a series of actions to advance the Companys strategy and respond to the severe economic downturn. The restructuring plan included the shutdown of a number of facilities and a global workforce reduction, which are targeted to be completed by the end of 2010. As a result of the shutdowns and global workforce reduction, the Company recorded pretax restructuring charges of $785 million in the fourth quarter of 2008. The charges consisted of asset write-downs and write-offs of $336 million, costs associated with exit or disposal activities of $128 million and severance costs of $321 million.
The severance component of the 2008 restructuring charges of $321 million was for the separation of approximately 3,000 employees under the terms of Dows ongoing benefit arrangements, primarily over two years. At December 31, 2009, severance of $289 million had been paid and a currency adjusted liability of $53 million remained for approximately 293 employees. In the nine-month period ended September 30, 2010, severance of $26 million was paid, leaving a currency adjusted liability of $26 million at September 30, 2010; $23 million was for employees who have left the Company and will continue to receive annuity payments primarily through 2013, and $3 million remained for approximately 65 employees.
10
The following table summarizes 2010 activities related to the Companys 2008 restructuring reserve:
2010 Activities Related to 2008 Restructuring | ||||||||||||
In millions | Costs associated with Exit or Disposal Activities |
Severance Costs |
Total | |||||||||
Reserve balance at December 31, 2009 |
$135 | $53 | $188 | |||||||||
Cash payments |
- | (26 | ) | (26 | ) | |||||||
Foreign currency impact |
(2 | ) | (1 | ) | (3 | ) | ||||||
Reserve balance at September 30, 2010 |
$133 | $ 26 | $159 |
Acquisition of Rohm and Haas
On April 1, 2009, the Company completed the acquisition of Rohm and Haas. Pursuant to the July 10, 2008 Agreement and Plan of Merger, Ramses Acquisition Corp., a direct wholly owned subsidiary of the Company, merged with and into Rohm and Haas, with Rohm and Haas continuing as the surviving corporation and becoming a direct wholly owned subsidiary of the Company.
The following table summarizes the fair values of the assets acquired and liabilities assumed from Rohm and Haas on April 1, 2009. During the measurement period, which ended on March 31, 2010, net adjustments of $145 million were made to the fair values of the assets acquired and liabilities assumed with a corresponding adjustment to goodwill. These adjustments are summarized in the table presented below. The balance sheet at December 31, 2009 has been retrospectively adjusted to reflect these adjustments as required by the accounting guidance for business combinations. No further adjustments have been made to the assets acquired and liabilities assumed since the end of the measurement period.
Assets Acquired and Liabilities Assumed on April 1, 2009 | ||||||||||||||||||||
In millions | Initial Valuation |
2009 Adjustments to Fair Value |
Dec. 31, 2009 |
2010 Adjustments to Fair Value |
March 31, 2010 |
|||||||||||||||
Purchase Price |
$15,681 | - | $15,681 | - | $15,681 | |||||||||||||||
Fair Value of Assets Acquired |
||||||||||||||||||||
Current assets |
$ 2,710 | - | $ 2,710 | $(18) | $ 2,692 | |||||||||||||||
Property |
3,930 | $(138) | 3,792 | - | 3,792 | |||||||||||||||
Other intangible assets (1) |
4,475 | 830 | 5,305 | - | 5,305 | |||||||||||||||
Other assets |
1,288 | 32 | 1,320 | - | 1,320 | |||||||||||||||
Net assets of the Salt business (2) |
1,475 | (167) | 1,308 | - | 1,308 | |||||||||||||||
Total Assets Acquired |
$13,878 | $557 | $14,435 | $(18) | $14,417 | |||||||||||||||
Fair Value of Liabilities and Noncontrolling Interests Assumed |
||||||||||||||||||||
Current liabilities |
$ 1,218 | $ (11) | $ 1,207 | $ (1) | $ 1,206 | |||||||||||||||
Long-term debt |
2,528 | 13 | 2,541 | - | 2,541 | |||||||||||||||
Accrued and other liabilities and noncontrolling interests |
702 | - | 702 | - | 702 | |||||||||||||||
Pension benefits |
1,119 | - | 1,119 | - | 1,119 | |||||||||||||||
Deferred tax liabilities noncurrent |
2,482 | 311 | 2,793 | 82 | 2,875 | |||||||||||||||
Total Liabilities and Noncontrolling Interests Assumed |
$ 8,049 | $ 313 | $ 8,362 | $ 81 | $ 8,443 | |||||||||||||||
Goodwill (1) |
$ 9,852 | $(244) | $ 9,608 | $ 99 | $ 9,707 |
(1) See Note G for additional information.
(2) Morton International, Inc.
11
The following table summarizes the major classes of assets and liabilities underlying the deferred tax liabilities resulting from the acquisition of Rohm and Haas:
Deferred Tax Liabilities Assumed on April 1, 2009 In millions |
As Adjusted | |||
Intangible assets |
$1,754 | |||
Property |
526 | |||
Long-term debt |
191 | |||
Inventories |
80 | |||
Other accruals and reserves |
324 | |||
Total Deferred Tax Liabilities |
$2,875 |
The acquisition resulted in the recognition of $9,707 million of goodwill, which is not deductible for tax purposes. See Note G for further information on goodwill, including the allocation by segment.
Rohm and Haas Acquisition and Integration Related Expenses
During the third quarter of 2010, integration expenses totaling $35 million ($98 million during the first nine months of 2010) were recorded related to the April 1, 2009 acquisition of Rohm and Haas. During the third quarter of 2009, pretax charges totaling $21 million ($121 million during the first nine months of 2009) were recorded for legal expenses and other transaction costs related to the acquisition. These charges, which were expensed in accordance with the accounting guidance for business combinations, were shown in Acquisition and integration related expenses and reflected in Corporate. An additional $34 million of acquisition-related retention expenses were incurred during the second quarter of 2009 and recorded in Cost of sales, Research and development expenses, and Selling, general and administrative expenses and reflected in Corporate.
Divestiture of the Styron Business Unit
On March 2, 2010, the Company announced the entry into a definitive agreement to sell the Styron business unit (Styron) to an affiliate of Bain Capital Partners. The definitive agreement specified the assets and liabilities related to the businesses and products to be included in the sale. On June 17, 2010, the sale was completed for $1,561 million, net of working capital adjustments and costs to sell, with proceeds subject to customary post-closing adjustments, to be finalized in subsequent periods. The proceeds included a $75 million long-term note receivable. The Company elected to acquire a 7.5 percent equity interest in the resulting privately held, global materials company. Businesses and products sold included: Styrenics polystyrene, acrylonitrile butadiene styrene, styrene acrylonitrile and expandable polystyrene; Emulsion Polymers; Polycarbonate and Compounds and Blends; Synthetic Rubber; and certain products from Dow Automotive Systems. Also included in the sale were certain styrene monomer assets and the Companys 50 percent ownership interest in Americas Styrenics LLC, a principal nonconsolidated affiliate. The transaction also resulted in several long-term supply, service and purchase agreements between Dow and Styron.
Styrons results of operations were not classified as discontinued operations, as the Company has continuing cash flows as a result of the supply, service and purchase agreements.
12
The following table presents the major classes of assets and liabilities divested on June 17, 2010 by operating segment:
Styron Assets and Liabilities Divested
In millions |
Perf Systems |
Perf Products |
Basic Plastics |
Hydro- carbons and Energy |
Corp | Total | ||||||||||||||||||
Inventories |
$ 76 | $ 96 | $152 | $144 | - | $ 468 | ||||||||||||||||||
Other current assets |
53 | 238 | 201 | 27 | $ 201 | 720 | ||||||||||||||||||
Investment in nonconsolidated affiliate |
- | - | 158 | - | - | 158 | ||||||||||||||||||
Net property |
140 | 137 | 126 | 8 | - | 411 | ||||||||||||||||||
Goodwill |
94 | 17 | 30 | - | - | 141 | ||||||||||||||||||
Other noncurrent assets |
- | - | - | - | 96 | 96 | ||||||||||||||||||
Total assets divested |
$363 | $488 | $667 | $179 | $ 297 | $1,994 | ||||||||||||||||||
Current liabilities |
- | - | - | - | $ 347 | $ 347 | ||||||||||||||||||
Other noncurrent liabilities |
- | - | - | - | 92 | 92 | ||||||||||||||||||
Total liabilities divested |
- | - | - | - | $ 439 | $ 439 | ||||||||||||||||||
Components of accumulated other comprehensive income divested |
- | - | - | - | $ 45 | $45 | ||||||||||||||||||
Net value divested |
$363 | $488 | $667 | $179 | $(187 | ) | $1,510 |
The Company recognized a pretax gain of $51 million on the sale in the second quarter of 2010, included in Sundry income (expense) net and reflected in the following operating segments: Performance Systems ($15 million), Performance Products ($26 million) and Basic Plastics ($10 million).
In the third quarter of 2010, a net $2 million pretax increase in the gain on the divestiture of Styron was recognized, related to a net gain on the sale of two small, related joint ventures, working capital adjustments and additional costs to sell. The adjustment was included in Sundry income (expense) net and impacted the Basic Plastics segment.
Divestiture of the Calcium Chloride Business
On June 30, 2009, the Company completed the sale of the Calcium Chloride business for net proceeds of $204 million and recognized a pretax gain of $162 million. The results of the Calcium Chloride business for the first nine months of 2009, including the second quarter of 2009 gain on the sale, are reflected as Income from discontinued operations, net of income taxes in the consolidated statements of income.
The following table presents the results of discontinued operations:
Discontinued Operations
In millions |
Three Months Sept. 30, 2009 |
Nine Months Sept. 30, 2009 |
||||
Net sales |
- | $ 70 | ||||
Income (loss) before income taxes (benefit) |
$(7) | $175 | ||||
Provision (credit) for income taxes |
$(3) | $ 65 | ||||
Income (loss) from discontinued operations, net of income taxes (benefit) |
$(4) | $110 |
Divestitures Required as a Condition to the Acquisition of Rohm and Haas
As a condition of the United States Federal Trade Commissions (FTCs) approval of the April 1, 2009 acquisition of Rohm and Haas, the Company was required to divest a portion of its acrylic monomer business, a portion of its specialty latex business and its hollow sphere particle business. The Company recognized an impairment charge of $205 million related to these assets in the second quarter of 2009 restructuring charge (see Note C).
13
On July 31, 2009, the Company entered into a definitive agreement that included the sale of the portion of its acrylic monomer business and the portion of its specialty latex business. The sale was completed on January 25, 2010. Additional impairment charges of $8 million related to these assets were recognized in the first quarter of 2010. In the second quarter of 2010, additional severance costs of $1 million and the write-off of other assets of $5 million were recognized (see Note C).
The Company completed the sale of its hollow sphere particle business in the second quarter of 2010 and recognized additional costs associated with disposal activities of $7 million, related to contract termination fees (see Note C).
Divestiture of Investments in Nonconsolidated Affiliates
On September 1, 2009, the Company completed the sale of its ownership interest in Total Raffinaderij Nederland N.V. (TRN), a nonconsolidated affiliate, and related inventory to Total S.A for $742 million. This resulted in a pretax net gain of $457 million, reflected in the Hydrocarbons and Energy segment, which consisted of a gain of $513 million reflected in Sundry income (expense) net and a charge of $56 million related to the recognition of hedging losses reflected in Cost of sales.
On September 30, 2009 the Company completed the sale of its ownership interest in the OPTIMAL Group of Companies (OPTIMAL), nonconsolidated affiliates, for $660 million to Petroliam Nasional Berhad. This resulted in a pretax net gain of $328 million included in Sundry income (expense) net and reflected in the following operating segments: Performance Systems ($1 million), Performance Products ($140 million) and Basic Chemicals ($187 million).
The following table provides a breakdown of inventories:
Inventories | Sept. 30, | Dec. 31, | ||||||
In millions | 2010 | 2009 | ||||||
Finished goods |
$4,214 | $3,887 | ||||||
Work in process |
1,666 | 1,593 | ||||||
Raw materials |
739 | 671 | ||||||
Supplies |
664 | 696 | ||||||
Total inventories |
$7,283 | $6,847 |
The reserves reducing inventories from the first-in, first-out (FIFO) basis to the last-in, first-out (LIFO) basis amounted to $816 million at September 30, 2010 and $818 million at December 31, 2009.
NOTE G GOODWILL AND OTHER INTANGIBLE ASSETS
The following table shows the carrying amount of goodwill by operating segment:
Goodwill | Electronic | Coatings | Hydro- | |||||||||||||||||||||||||||||
In millions | and Specialty Materials |
and Infra- structure |
Health and Ag Sciences |
Perf Systems |
Perf Products |
Basic Plastics |
carbons and Energy |
Total | ||||||||||||||||||||||||
Net goodwill at Dec. 31, 2009 |
$5,950 | $4,079 | $1,546 | $962 | $548 | $65 | $63 | $13,213 | ||||||||||||||||||||||||
Divestiture of Styron |
- | - | - | (94 | ) | (17 | ) | (30 | ) | - | (141) | |||||||||||||||||||||
Divestiture of the Powder Coatings business |
- | (4 | ) | - | - | - | - | - | (4) | |||||||||||||||||||||||
Foreign currency impact |
(27 | ) | (30 | ) | - | (7 | ) | (4 | ) | - | - | (68) | ||||||||||||||||||||
Net goodwill at September 30, 2010 |
$5,923 | $4,045 | $1,546 | $861 | $527 | $35 | $63 | $13,000 |
14
The recording of the April 1, 2009 acquisition of Rohm and Haas (see Note D) resulted in goodwill of $9,707 million, which is not deductible for tax purposes. During the first quarter of 2010, goodwill related to the acquisition of Rohm and Haas increased $99 million for net adjustments made during the measurement period to the fair values of the assets acquired and liabilities assumed. In the table above, these retrospective adjustments are reflected in the net goodwill at December 31, 2009, in accordance with the accounting guidance for business combinations. The retrospective adjustments increased goodwill for the operating segments as follows: Electronic and Specialty Materials ($39 million), Coatings and Infrastructure ($51 million), Health and Agricultural Sciences ($2 million), Performance Systems ($3 million) and Performance Products ($4 million).
On June 1, 2010, the Company divested its Powder Coatings business, including $4 million of associated goodwill. As a result of the June 17, 2010 divestiture of Styron, $141 million of associated goodwill and $16 million of intangible assets were divested (see Note E). Accumulated goodwill impairments were $250 million at September 30, 2010 and December 31, 2009
The following table provides information regarding the Companys other intangible assets:
Other Intangible Assets | At September 30, 2010 | At December 31, 2009 | ||||||||||||||||||||||
In millions | Gross Carrying Amount |
Accumulated Amortization |
Net | Gross Carrying Amount |
Accumulated Amortization |
Net | ||||||||||||||||||
Intangible assets with finite lives: |
||||||||||||||||||||||||
Licenses and intellectual property |
$1,722 | $ (423 | ) | $1,299 | $1,729 | $ (320 | ) | $1,409 | ||||||||||||||||
Patents |
121 | (94 | ) | 27 | 140 | (107 | ) | 33 | ||||||||||||||||
Software |
930 | (486 | ) | 444 | 875 | (439 | ) | 436 | ||||||||||||||||
Trademarks |
692 | (152 | ) | 540 | 694 | (110 | ) | 584 | ||||||||||||||||
Customer related |
3,628 | (426 | ) | 3,202 | 3,613 | (261 | ) | 3,352 | ||||||||||||||||
Other |
121 | (73 | ) | 48 | 142 | (65 | ) | 77 | ||||||||||||||||
Total other intangible assets, finite lives |
$7,214 | $(1,654 | ) | $5,560 | $7,193 | $(1,302 | ) | $5,891 | ||||||||||||||||
IPR&D (1), indefinite lives |
65 | - | 65 | 75 | - | 75 | ||||||||||||||||||
Total other intangible assets |
$7,279 | $(1,654 | ) | $5,625 | $7,268 | $(1,302 | ) | $5,966 |
(1) In-process research and development (IPR&D) purchased in a business combination.
The following table provides information regarding amortization expense:
Amortization Expense | Three Months Ended | Nine Months Ended | ||||||||||||||
In millions |
|
Sept. 30, 2010 |
|
|
Sept. 30, 2009 |
|
|
Sept. 30, 2010 |
|
|
Sept. 30, 2009 |
| ||||
Other intangible assets, excluding software |
$124 | $108 | $377 | $242 | ||||||||||||
Software, included in Cost of sales |
$21 | $22 | $64 | $55 |
Total estimated amortization expense for 2010 and the five succeeding fiscal years is as follows:
Estimated Amortization Expense In millions |
||||
2010 |
$592 | |||
2011 |
$632 | |||
2012 |
$566 | |||
2013 |
$544 | |||
2014 |
$521 | |||
2015 |
$503 |
15
NOTE H FINANCIAL INSTRUMENTS
Investments
The Companys investments in marketable securities are primarily classified as available-for-sale.
Investing Results
In millions |
Nine Months Sept. 30, 2010 |
Nine Months Sept. 30, 2009 |
||||||
Proceeds from sales of available-for-sale securities |
$680 | $263 | ||||||
Gross realized gains |
$31 | $7 | ||||||
Gross realized losses |
$(62 | ) | $(21 | ) |
The following table summarizes the contractual maturities of the Companys investments in debt securities:
Contractual Maturities of Debt Securities at September 30, 2010 |
||||||||
In millions | Amortized Cost | Fair Value | ||||||
Within one year |
$ 40 | $ 41 | ||||||
One to five years |
568 | 624 | ||||||
Six to ten years |
592 | 658 | ||||||
After ten years |
257 | 291 | ||||||
Total |
$1,457 | $1,614 |
At September 30, 2010, the Company had $650 million of held-to-maturity securities (primarily Treasury Bills) classified as cash equivalents, as these securities had original maturities of three months or less. At December 31, 2009, the amount held was zero. The Companys investments in held-to-maturity securities are held at amortized cost, which approximates fair value. At September 30, 2010, the Company had investments in money market funds of $57 million classified as cash equivalents ($164 million at December 31, 2009).
The net unrealized gain recognized during the nine-month period ended September 30, 2010 on trading securities held at September 30, 2010 was $22 million.
The following tables provide the fair value and gross unrealized losses of the Companys investments that were deemed to be temporarily impaired at September 30, 2010 and December 31, 2009, aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position:
Temporarily Impaired Securities at September 30, 2010 | ||||||||||||||||||||||||
Less than 12 months | 12 months or more | Total | ||||||||||||||||||||||
In millions | Fair Value |
Unrealized Losses |
Fair Value |
Unrealized Losses |
Fair Value |
Unrealized Losses |
||||||||||||||||||
Debt securities: |
||||||||||||||||||||||||
U.S. Treasury obligations and direct obligations of U.S. government agencies |
$ 9 | $(1) | - | - | $ 9 | $ (1) | ||||||||||||||||||
Equity securities |
185 | (8) | $3 | $(1) | 188 | (9) | ||||||||||||||||||
Total temporarily impaired securities |
$194 | $(9) | $3 | $(1) | $197 | $(10) |
16
Temporarily Impaired Securities at December 31, 2009 | ||||||||||||||||||||||||
Less than 12 months | 12 months or more | Total | ||||||||||||||||||||||
In millions | Fair Value |
Unrealized Losses |
Fair Value |
Unrealized Losses |
Fair Value |
Unrealized Losses |
||||||||||||||||||
Debt securities: |
||||||||||||||||||||||||
U.S. Treasury obligations and direct obligations of U.S. government agencies |
$217 | $(4) | - | - | $217 | $(4) | ||||||||||||||||||
Corporate bonds |
27 | (1) | $13 | $(1) | 40 | (2) | ||||||||||||||||||
Total debt securities |
$244 | $(5) | $13 | $(1) | $257 | $(6) | ||||||||||||||||||
Equity securities |
40 | (2) | 7 | (1) | 47 | (3) | ||||||||||||||||||
Total temporarily impaired securities |
$284 | $(7) | $20 | $(2) | $304 | $(9) |
Portfolio managers regularly review the Companys holdings to determine if any investments are other-than-temporarily impaired. The analysis includes reviewing the amount of a temporary impairment, as well as the length of time it has been impaired. In addition, specific guidelines for each instrument type are followed to determine if an other-than-temporary impairment has occurred.
For debt securities, the credit rating of the issuer, current credit rating trends, the trends of the issuers overall sector, the ability of the issuer to pay expected cash flows and the length of time the security has been in a loss position are considered in determining whether unrealized losses represent an other-than-temporary impairment. The Company did not have any credit-related losses during the nine-month period ended September 30, 2010.
For equity securities, the Companys investments are primarily in Standard & Poors (S&P) 500 companies; however, the Companys policies allow investments in companies outside of the S&P 500. The largest holdings are Exchange Traded Funds that represent the S&P 500 index or an S&P 500 sector or subset. The Company considers the evidence to support the recovery of the cost basis of a security including volatility of the stock, the length of time the security has been in a loss position, value and growth expectations, and overall market and sector fundamentals, as well as technical analysis, in determining whether unrealized losses represent an other-than-temporary impairment. In the nine-month period ended September 30, 2010, other-than-temporary impairment write-downs on investments still held by the Company were $4 million.
The aggregate cost of the Companys cost method investments totaled $161 million at September 30, 2010 and $129 million at December 31, 2009. Due to the nature of these investments, the fair market value is not readily determinable. These investments are reviewed for impairment indicators. In the nine-month period ended September 30, 2010, the Companys impairment analysis identified indicators that resulted in a reduction in the cost basis of these investments of $21 million.
17
The following table summarizes the fair value of financial instruments at September 30, 2010 and December 31, 2009:
Fair Value of Financial Instruments | ||||||||||||||||||||||||||||||||
At September 30, 2010 | At December 31, 2009 | |||||||||||||||||||||||||||||||
In millions | Cost | Gain | Loss | Fair Value | Cost | Gain | Loss | Fair Value | ||||||||||||||||||||||||
Marketable securities (1): |
||||||||||||||||||||||||||||||||
Debt securities: |
||||||||||||||||||||||||||||||||
U.S. Treasury obligations and direct obligations of U.S. government agencies |
$ 655 | $ 65 | $ (1) | $ 719 | $ 676 | $ 25 | $(4) | $ 697 | ||||||||||||||||||||||||
Corporate bonds |
802 | 93 | - | 895 | 868 | 56 | (2) | 922 | ||||||||||||||||||||||||
Total debt securities |
$1,457 | $158 | $ (1) | $1,614 | $1,544 | $ 81 | $(6) | $1,619 | ||||||||||||||||||||||||
Equity securities |
508 | 62 | (9) | 561 | 455 | 65 | (3) | 517 | ||||||||||||||||||||||||
Total marketable securities |
$1,965 | $220 | $(10) | $2,175 | $1,999 | $146 | $(9) | $2,136 | ||||||||||||||||||||||||
Long-term debt including debt due within one |
$(19,802) | $72 | $(2,555) | $(22,285) | $(20,234) | $126 | $(1,794) | $(21,902) | ||||||||||||||||||||||||
Derivatives relating to: |
||||||||||||||||||||||||||||||||
Foreign currency |
- | $77 | $(49) | $28 | - | $81 | $(20) | $61 | ||||||||||||||||||||||||
Commodities |
- | $16 | $(7) | $9 | - | $5 | $(18) | $(13) |
(1) Included in Other investments in the consolidated balance sheets.
(2) Cost includes fair value adjustments of $24 million at September 30, 2010 and $25 million at December 31, 2009.
Risk Management
Dows business operations give rise to market risk exposure due to changes in interest rates, foreign currency exchange rates, commodity prices and other market factors such as equity prices. To manage such risks effectively, the Company enters into hedging transactions, pursuant to established guidelines and policies, which enable it to mitigate the adverse effects of financial market risk. Derivatives used for this purpose are designated as cash flow, fair value or net foreign investment hedges where appropriate. The guidance requires companies to recognize all derivative instruments as either assets or liabilities at fair value. A secondary objective is to add value by creating additional nonspecific exposures within established limits and policies; derivatives used for this purpose are not designated as hedges. The potential impact of creating such additional exposures is not material to the Companys results.
The Companys risk management program for interest rate, foreign currency and commodity risks is based on fundamental, mathematical and technical models that take into account the implicit cost of hedging. Risks created by derivative instruments and the mark-to-market valuations of positions are strictly monitored at all times, using value at risk and stress tests. Credit risk arising from these contracts is not significant because the Company minimizes counterparty concentration, deals primarily with major financial institutions of solid credit quality, and the majority of its hedging transactions mature in less than three months. In addition, the Company minimizes concentrations of credit risk through its global orientation in diverse businesses with a large number of diverse customers and suppliers. It is the Companys policy not to have credit-risk-related contingent features in its derivative instruments. The Company does not anticipate losses from credit risk, and the net cash requirements arising from counterparty risk associated with risk management activities are not expected to be material in 2010. No significant concentration of credit risk existed at September 30, 2010.
The Company reviews its overall financial strategies and the impacts from using derivatives in its risk management program with the Companys Board of Directors and revises its strategies as market conditions dictate.
Interest Rate Risk Management
The Company enters into various interest rate contracts with the objective of lowering funding costs or altering interest rate exposures related to fixed and variable rate obligations. In these contracts, the Company agrees with other parties to exchange, at specified intervals, the difference between fixed and floating interest amounts calculated on an agreed-upon notional principal amount. At September 30, 2010, the Company had open interest rate swaps with maturity dates no later than 2012.
18
Foreign Currency Risk Management
The Companys global operations require active participation in foreign exchange markets. The Company enters into foreign exchange forward contracts and options, and cross-currency swaps to hedge various currency exposures or create desired exposures. Exposures primarily relate to assets, liabilities and bonds denominated in foreign currencies, as well as economic exposure, which is derived from the risk that currency fluctuations could affect the dollar value of future cash flows related to operating activities. The primary business objective of the activity is to optimize the U.S. dollar value of the Companys assets, liabilities and future cash flows with respect to exchange rate fluctuations. Assets and liabilities denominated in the same foreign currency are netted, and only the net exposure is hedged. At September 30, 2010, the Company had forward contracts, options and cross-currency swaps to buy, sell or exchange foreign currencies. These contracts had various expiration dates, primarily in the fourth quarter of 2010.
Commodity Risk Management
The Company has exposure to the prices of commodities in its procurement of certain raw materials. The primary purpose of commodity hedging activities is to manage the price volatility associated with these forecasted inventory purchases. At September 30, 2010, the Company had futures contracts, options and swaps to buy, sell or exchange commodities. These agreements have various expiration dates through 2011.
Accounting for Derivative Instruments and Hedging Activities
Cash Flow Hedges
For derivatives that are designated and qualify as cash flow hedging instruments, the effective portion of the gain or loss on the derivative is recorded in Accumulated other comprehensive income (loss) (AOCI); it is reclassified to Cost of sales in the same period or periods that the hedged transaction affects income. The unrealized amounts in AOCI fluctuate based on changes in the fair value of open contracts at the end of each reporting period. The Company anticipates volatility in AOCI and net income from its cash flow hedges. The amount of volatility varies with the level of derivative activities and market conditions during any period. Gains and losses on the derivative representing either hedge ineffectiveness or hedge components excluded from the assessment of effectiveness are recognized in current period income.
The net loss from previously terminated interest rate cash flow hedges included in AOCI was $2 million after tax at September 30, 2010 and December 31, 2009. The Company had open interest rate derivatives with a notional U.S. dollar equivalent of $32 million at September 30, 2010 ($30 million at December 31, 2009).
Current open foreign currency forward contracts hedge the currency risk of forecasted feedstock purchase transactions until February 2011. The effective portion of the mark-to-market effects of the foreign currency forward contracts is recorded in AOCI; it is reclassified to income in the same period or periods that the underlying feedstock purchase affects income. The net loss from the foreign currency hedges included in AOCI at September 30, 2010 was $1 million after tax ($5 million at December 31, 2009). At September 30, 2010, the Company had open forward contracts with various expiration dates to buy, sell or exchange foreign currencies with a notional U.S. dollar equivalent of $957 million ($645 million at December 31, 2009).
Commodity swaps, futures and option contracts with maturities of not more than 36 months are utilized and designated as cash flow hedges of forecasted commodity purchases. Current open contracts hedge forecasted transactions until December 2011. The effective portion of the mark-to-market effect of the cash flow hedge instrument is recorded in AOCI; it is reclassified to income in the same period or periods that the underlying commodity purchase affects income. The net loss from commodity hedges included in AOCI was $1 million at September 30, 2010 and zero at December 31, 2009. At September 30, 2010 and December 31, 2009, the Company had the following aggregate notionals of outstanding commodity forward contracts to hedge forecasted purchases:
Commodity | Sept. 30, 2010 |
Dec. 31, 2009 |
Notional Volume Unit | |||||||
Crude Oil |
- | 0.7 | million barrels | |||||||
Ethane |
1.6 | - | million barrels | |||||||
Naphtha |
- | 50 | kilotons | |||||||
Natural Gas |
5.1 | 2.0 | million million British thermal units |
19
Fair Value Hedges
For derivative instruments that are designated and qualify as fair value hedges, the gain or loss on the derivative as well as the offsetting loss or gain on the hedged item attributable to the hedged risk are recognized in current period income and reflected as Interest expense and amortization of debt discount in the consolidated statements of income. The short-cut method is used when the criteria are met. The Company had no open interest rate swaps designated as fair value hedges of underlying fixed rate debt obligations at September 30, 2010 and December 31, 2009.
Net Foreign Investment Hedges
For derivative instruments that are designated and qualify as net foreign investment hedges, the effective portion of the gain or loss on the derivative is included in Cumulative Translation Adjustments in AOCI. The results of hedges of the Companys net investment in foreign operations included in Cumulative Translation Adjustments in AOCI was a net gain of $62 million after tax at September 30, 2010 (net loss of $56 million after tax at December 31, 2009). At September 30, 2010, the Company had open forward contracts or outstanding options to buy, sell or exchange foreign currencies that were designated as net foreign investment hedges with fourth quarter 2010 expiration dates and a notional U.S. dollar equivalent of $197 million (zero at December 31, 2009). At September 30, 2010, the Company had outstanding foreign-currency denominated debt designated as a hedge of net foreign investment of $1,263 million ($1,879 million at December 31, 2009).
Other Derivative Instruments
The Company utilizes futures, options and swap instruments that are effective as economic hedges of commodity price exposures, but do not meet the hedge accounting criteria in the accounting guidance for derivatives and hedging. At September 30, 2010 and December 31, 2009, the Company had the following aggregate notionals of outstanding commodity contracts:
Commodity | Sept. 30, 2010 |
Dec. 31, 2009 |
Notional Volume Unit | |||||||
Ethane |
3.9 | 0.9 | million barrels | |||||||
Natural Gas |
14.0 | 2.8 | million million British thermal units |
The Company also uses foreign exchange forward contracts, options, and cross-currency swaps that are not designated as hedging instruments primarily to manage foreign currency and interest rate exposure. The Company had open foreign exchange contracts with various expiration dates to buy, sell or exchange foreign currencies and a notional U.S. dollar equivalent of $12,464 million at September 30, 2010 ($15,312 million at December 31, 2009).
20
The following table provides the fair value and gross balance sheet classification of derivative instruments at September 30, 2010 and December 31, 2009:
Fair Value of Derivative Instruments | Sept. 30, | Dec. 31, | ||||||||
In millions | Balance Sheet Classification | 2010 | 2009 | |||||||
Asset Derivatives |
||||||||||
Derivatives designated as hedges: |
||||||||||
Foreign currency |
Accounts and notes receivable Other | $ 27 | $ 4 | |||||||
Commodities |
Accounts and notes receivable Other | 10 | 4 | |||||||
Total derivatives designated as hedges |
$ 37 | $ 8 | ||||||||
Derivatives not designated as hedges: |
||||||||||
Foreign currency |
Accounts and notes receivable Other | $135 | $125 | |||||||
Commodities |
Accounts and notes receivable Other | 25 | 28 | |||||||
Total derivatives not designated as hedges |
$160 | $153 | ||||||||
Total asset derivatives |
$197 | $161 | ||||||||
Liability Derivatives |
||||||||||
Derivatives designated as hedges: |
||||||||||
Foreign currency |
Accounts payable Other | $ 22 | $ 3 | |||||||
Commodities |
Accounts payable Other | 15 | - | |||||||
Total derivatives designated as hedges |
$ 37 | $ 3 | ||||||||
Derivatives not designated as hedges: |
||||||||||
Foreign currency |
Accounts payable Other | $112 | $ 65 | |||||||
Commodities |
Accounts payable Other | 21 | 42 | |||||||
Total derivatives not designated as hedges |
$133 | $107 | ||||||||
Total liability derivatives |
$170 | $110 |
21
Effect of Derivative Instruments for the three months ended September 30, 2010
In millions |
Change in Unrealized Gain (Loss) in AOCI (1,2) |
Income Statement Classification |
Gain (Loss) Reclassified from AOCI to Income (3) |
Additional Gain Recognized in Income (3,4) |
||||||||||||
Derivatives designated as hedges: |
||||||||||||||||
Cash flow: |
||||||||||||||||
Commodities |
$4 | Cost of sales | $(10) | - | ||||||||||||
Foreign currency |
(16) | Cost of sales | 2 | - | ||||||||||||
Net foreign investment: |
||||||||||||||||
Foreign currency |
4 | n/a | - | - | ||||||||||||
Total derivatives designated as hedges |
$(8) | $ (8) | - | |||||||||||||
Derivatives not designated as hedges: |
||||||||||||||||
Foreign currency (6) |
- | Sundry income net | - | $44 | ||||||||||||
Commodities |
- | Cost of sales | - | 5 | ||||||||||||
Total derivatives not designated as hedges |
- | - | $49 | |||||||||||||
Total derivatives |
$(8) | $(8) | $49 | |||||||||||||
Effect of Derivative Instruments for the three months ended September 30, 2009
In millions |
Change in Unrealized Gain in AOCI (1,2) |
Income Statement Classification |
Gain (Loss) Reclassified from AOCI to Income (3) |
Additional Loss Recognized in Income (3,4) |
||||||||||||
Derivatives designated as hedges: |
||||||||||||||||
Fair value: |
||||||||||||||||
Interest rates |
- | Interest expense (5) | - | $(1) | ||||||||||||
Cash flow: |
||||||||||||||||
Interest rates |
- | Cost of sales | $ (3) | - | ||||||||||||
Commodities |
- | Cost of sales | (73) | - | ||||||||||||
Foreign currency |
- | Cost of sales | 7 | - | ||||||||||||
Net foreign investment: |
||||||||||||||||
Foreign currency |
$5 | n/a | - | - | ||||||||||||
Total derivatives designated as hedges |
$5 | $(69) | $(1) | |||||||||||||
Derivatives not designated as hedges: |
||||||||||||||||
Foreign currency (6) |
- | Sundry income net | - | $(7) | ||||||||||||
Total derivatives |
$5 | $(69) | $(8) |
(1) | Accumulated other comprehensive income (loss) (AOCI). |
(2) | Net unrealized gains/losses from hedges related to interest rates and commodities are included in Accumulated Derivative Loss Net hedging results in the consolidated statements of equity; net unrealized gains/losses from hedges related to foreign currency (net of tax) are included in Cumulative Translation Adjustments Translation adjustments in the consolidated statements of equity. |
(3) | Pretax amounts. |
(4) | Amounts impacting income not related to AOCI reclassification; also includes immaterial amounts of hedge ineffectiveness. |
(5) | Interest expense and amortization of debt discount. |
(6) | Foreign currency derivatives not designated as hedges are offset by foreign exchange gains/losses resulting from the underlying exposures of foreign currency denominated assets and liabilities. |
22
Effect of Derivative Instruments for the nine months ended September 30, 2010
In millions |
Change
in Unrealized Gain (Loss) in AOCI (1,2) |
Income Statement Classification |
Loss Reclassified from AOCI to Income (3) |
Additional Gain (Loss) |
||||||||||||
Derivatives designated as hedges: |
||||||||||||||||
Fair value: |
||||||||||||||||
Interest rates |
$ (1) | Interest expense (5) | - | $ (1) | ||||||||||||
Cash flow: |
||||||||||||||||
Commodities |
(14) | Cost of sales | $(14) | - | ||||||||||||
Foreign currency |
4 | Cost of sales | (1) | - | ||||||||||||
Net foreign investment: |
||||||||||||||||
Foreign currency |
(16) | n/a | - | - | ||||||||||||
Total derivatives designated as hedges |
$(27) | $(15) | $ (1) | |||||||||||||
Derivatives not designated as hedges: |
||||||||||||||||
Foreign currency (6) |
- | Sundry income net | - | $ 157 | ||||||||||||
Commodities |
- | Cost of sales | - | 1 | ||||||||||||
Total derivatives not designated as hedges |
- | - | $ 158 | |||||||||||||
Total derivatives |
$(27) | $(15) | $ 157 | |||||||||||||
Effect of Derivative Instruments for the nine months ended September 30, 2009
In millions |
Change
in Unrealized Gain (Loss) in AOCI (1,2) |
Income Statement Classification |
Gain (Loss) Reclassified from AOCI to Income (3) |
Additional Loss Recognized in Income (3,4) |
||||||||||||
Derivatives designated as hedges: |
||||||||||||||||
Fair value: |
||||||||||||||||
Interest rates |
- | Interest expense (5) | - | $ (1) | ||||||||||||
Cash flow: |
||||||||||||||||
Interest rates |
- | Cost of sales | $ (9) | - | ||||||||||||
Commodities |
$(6) | Cost of sales | (306) | (1) | ||||||||||||
Foreign currency |
(10) | Cost of sales | 24 | - | ||||||||||||
Net foreign investment: |
||||||||||||||||
Foreign currency |
1 | n/a | - | - | ||||||||||||
Total derivatives designated as hedges |
$(15) | $ (291) | $ (2) | |||||||||||||
Derivatives not designated as hedges: |
||||||||||||||||
Foreign currency (6) |
- | Sundry income net | - | $(38) | ||||||||||||
Commodities |
- | Cost of sales | - | (1) | ||||||||||||
Total derivatives not designated as hedges |
- | - | $(39) | |||||||||||||
Total derivatives |
$(15) | $ (291) | $(41) |
(1) | Accumulated other comprehensive income (loss) (AOCI). |
(2) | Net unrealized gains/losses from hedges related to interest rates and commodities are included in Accumulated Derivative Loss Net hedging results in the consolidated statements of equity; net unrealized gains/losses from hedges related to foreign currency (net of tax) are included in Cumulative Translation Adjustments Translation adjustments in the consolidated statements of equity. |
(3) | Pretax amounts. |
(4) | Amounts impacting income not related to AOCI reclassification; also includes immaterial amounts of hedge ineffectiveness. |
(5) | Interest expense and amortization of debt discount. |
(6) | Foreign currency derivatives not designated as hedges are offset by foreign exchange gains/losses resulting from the underlying exposures of foreign currency denominated assets and liabilities. |
The net after-tax amounts to be reclassified from AOCI to income within the next 12 months are a $2 million loss for interest rate contracts and a $1 million loss for foreign currency contracts.
23
NOTE I FAIR VALUE MEASUREMENTS
The following table summarizes the bases used to measure certain assets and liabilities at fair value on a recurring basis in the consolidated balance sheets:
Basis of Fair Value Measurements on a Recurring Basis at September 30, 2010
In millions |
Quoted Prices (Level 1) |
Significant (Level 2) |
Significant (Level 3) |
Counterparty and Cash Collateral Netting (1) |
Total | |||||||||||||||
Assets at fair value: |
||||||||||||||||||||
Accounts and notes receivable Other (2) |
- | - | $1,312 | - | $1,312 | |||||||||||||||
Equity securities (3) |
$525 | $ 36 | - | - | 561 | |||||||||||||||
Debt securities: (3) |
||||||||||||||||||||
U.S. Treasury obligations and direct obligations of U.S. government agencies |
- | 719 | - | - | 719 | |||||||||||||||
Corporate bonds |
- | 895 | - | - | 895 | |||||||||||||||
Derivatives relating to: (4) |
||||||||||||||||||||
Foreign currency |
- | 162 | - | $ (85) | 77 | |||||||||||||||
Commodities |
9 | 26 | - | (19) | 16 | |||||||||||||||
Total assets at fair value |
$534 | $ 1,838 | $1,312 | $(104) | $3,580 | |||||||||||||||
Liabilities at fair value: |
||||||||||||||||||||
Derivatives relating to: (4) |
||||||||||||||||||||
Foreign currency |
- | $ 134 | - | $ (85) | $ 49 | |||||||||||||||
Commodities |
$ 9 | 27 | - | (29) | 7 | |||||||||||||||
Total liabilities at fair value |
$ 9 | $ 161 | - | $(114) | $ 56 | |||||||||||||||
Basis of Fair Value Measurements on a Recurring Basis at December 31, 2009
In millions |
Quoted Prices (Level 1) |
Significant (Level 2) |
Counterparty and Cash Collateral Netting (1) |
Total | ||||||||||||||||
Assets at fair value: |
||||||||||||||||||||
Equity securities (3) |
$483 | $ 34 | - | $ 517 | ||||||||||||||||
Debt securities (3) |
||||||||||||||||||||
U.S. Treasury obligations and direct obligations of U.S. government agencies |
- | 697 | - | 697 | ||||||||||||||||
Corporate bonds |
- | 922 | - | 922 | ||||||||||||||||
Derivatives relating to: (4) |
||||||||||||||||||||
Foreign currency |
- | 129 | $(48) | 81 | ||||||||||||||||
Commodities |
28 | 4 | (27) | 5 | ||||||||||||||||
Total assets at fair value |
$511 | $ 1,786 | $(75) | $2,222 | ||||||||||||||||
Liabilities at fair value: |
||||||||||||||||||||
Derivatives relating to: (4) |
||||||||||||||||||||
Foreign currency |
- | $ 68 | $(48) | $ 20 | ||||||||||||||||
Commodities |
$ 24 | 18 | (24) | 18 | ||||||||||||||||
Total liabilities at fair value |
$ 24 | $ 86 | $(72) | $ 38 |
(1) | Cash collateral is classified as Accounts and notes receivable Other in the consolidated balance sheets. Amounts represent the estimated net settlement amount when applying netting and set-off rights included in master netting arrangements between the Company and its counterparties and the payable or receivable for cash collateral held or placed with the same counterparty. |
(2) | See Note K for additional information on transfers of financial assets. |
(3) | The Companys investments in equity and debt securities are primarily classified as available-for-sale and are included in Other investments in the consolidated balance sheets. |
(4) | See Note H for the classification of derivatives in the consolidated balance sheets. |
24
Assets and liabilities related to forward contracts, interest rate swaps, currency swaps, options and other conditional or exchange contracts executed with the same counterparty under a master netting arrangement are netted. Collateral accounts are netted with corresponding assets and liabilities. The Company posted cash collateral of $10 million at September 30, 2010, classified as Accounts and notes receivable Other in the consolidated balance sheets.
For assets and liabilities classified as Level 1 measurements (measured using quoted prices in active markets), the total fair value is either the price of the most recent trade at the time of the market close or the official close price, as defined by the exchange in which the asset is most actively traded on the last trading day of the period, multiplied by the number of units held without consideration of transaction costs.
For assets and liabilities classified as Level 2 measurements, the fair value is based on the price a dealer would pay for the security or similar securities, adjusted for any terms specific to that asset or liability. Market inputs are obtained from well established and recognized vendors of market data and subjected to tolerance/quality checks. For derivative assets and liabilities, the fair value is calculated using standard industry models used to calculate the fair value of the various financial instruments based on significant observable market inputs, such as foreign exchange rates, commodity prices, swap rates, interest rates and implied volatilities obtained from various market sources.
For all other assets and liabilities for which observable inputs are used, fair value is derived through the use of fair value models, such as a discounted cash flow model or other standard pricing models. See Note H for further information on the types of instruments used by the Company for risk management.
There were no significant transfers between Levels 1 and 2 during the nine months ended September 30, 2010.
For assets classified as Level 3 measurements, the fair value is based on significant unobservable inputs including assumptions where there is little, if any, market activity. The fair value of the Companys interests held in trade receivable conduits is determined by calculating the expected amount of cash to be received using the key input of anticipated credit losses in the portfolio of receivables sold that have not yet been collected (1.44 percent for North America and zero for Europe at September 30, 2010). Given the short-term nature of the underlying receivables, discount rate and prepayments are not factors in determining the fair value of the interests. See Note K for further information on assets classified as Level 3 measurements.
The following table summarizes the changes in fair value measurements using Level 3 inputs for the three and nine months ended September 30, 2010:
Fair Value Measurements Using Level 3 Inputs Interests Held in Trade Receivable Conduits (1) In millions |
Three Months Ended Sept. 30, 2010 |
Nine Months Ended Sept. 30, 2010 |
||||||
Balance at beginning of period |
$1,206 | - | ||||||
Gain (Loss) included in earnings |
(2) | $ 7 | ||||||
Purchases, sales and settlements North America |
100 | 1,153 | ||||||
Purchases, sales and settlements - Europe |
8 | 152 | ||||||
Balance at September 30, 2010 |
$1,312 | $1,312 |
(1) | Included in Accounts and notes receivable Other in the consolidated balance sheets. |
The following table summarizes the bases used to measure certain assets and liabilities at fair value on a nonrecurring basis in the consolidated balance sheets:
Basis of Fair Value Measurements on a Nonrecurring Basis at September 30, 2009
In millions |
Significant (Level 3) |
Total Losses |
||||||
Assets at fair value: |
||||||||
Long-lived assets |
$ | 26 | $ | (399 | ) |
25
As part of the restructuring plan that was approved on June 30, 2009, the Company will shut down a number of manufacturing facilities by the end of 2011. In the second quarter of 2009, long-lived assets with a carrying value of $425 million were written down to the fair value of $26 million, resulting in an impairment charge of $399 million, which was included in the second quarter of 2009 restructuring charge (see Note C). The long-lived assets were valued based on bids received from third parties and using discounted cash flow analysis based on assumptions that market participants would use. Key inputs included anticipated revenues, associated manufacturing costs, capital expenditures and discount, growth and tax rates.
NOTE J COMMITMENTS AND CONTINGENT LIABILITIES
Litigation
Breast Implant Matters
On May 15, 1995, Dow Corning Corporation (Dow Corning), in which the Company is a 50 percent shareholder, voluntarily filed for protection under Chapter 11 of the Bankruptcy Code to resolve litigation related to Dow Cornings breast implant and other silicone medical products. On June 1, 2004, Dow Cornings Joint Plan of Reorganization (the Joint Plan) became effective and Dow Corning emerged from bankruptcy. The Joint Plan contains release and injunction provisions resolving all tort claims brought against various entities, including the Company, involving Dow Cornings breast implant and other silicone medical products.
To the extent not previously resolved in state court actions, cases involving Dow Cornings breast implant and other silicone medical products filed against the Company were transferred to the U.S. District Court for the Eastern District of Michigan (the District Court) for resolution in the context of the Joint Plan. On October 6, 2005, all such cases then pending in the District Court against the Company were dismissed. Should cases involving Dow Cornings breast implant and other silicone medical products be filed against the Company in the future, they will be accorded similar treatment. It is the opinion of the Companys management that the possibility is remote that a resolution of all future cases will have a material adverse impact on the Companys consolidated financial statements.
As part of the Joint Plan, Dow and Corning Incorporated agreed to provide a credit facility to Dow Corning in an aggregate amount of $300 million, which was reduced to $200 million effective June 1, 2010. The Companys share of the credit facility was originally $150 million, but was reduced to $100 million effective June 1, 2010, and is subject to the terms and conditions stated in the Joint Plan. At September 30, 2010, no draws had been taken against the credit facility.
DBCP Matters
Numerous lawsuits have been brought against the Company and other chemical companies, both inside and outside of the United States, alleging that the manufacture, distribution or use of pesticides containing dibromochloropropane (DBCP) has caused personal injury and property damage, including contamination of groundwater. It is the opinion of the Companys management that the possibility is remote that the resolution of such lawsuits will have a material adverse impact on the Companys consolidated financial statements.
Environmental Matters
Accruals for environmental matters are recorded when it is probable that a liability has been incurred and the amount of the liability can be reasonably estimated, based on current law and existing technologies. At September 30, 2010, the Company had accrued obligations of $594 million for environmental remediation and restoration costs, including $63 million for the remediation of Superfund sites. This is managements best estimate of the costs for remediation and restoration with respect to environmental matters for which the Company has accrued liabilities, although the ultimate cost with respect to these particular matters could range up to approximately twice that amount. Consequently, it is reasonably possible that environmental remediation and restoration costs in excess of amounts accrued could have a material adverse impact on the Companys results of operations, financial condition and cash flows. It is the opinion of the Companys management, however, that the possibility is remote that costs in excess of the range disclosed will have a material adverse impact on the Companys results of operations, financial condition and cash flows. Inherent uncertainties exist in these estimates primarily due to unknown conditions, changing governmental regulations and legal standards regarding liability, and emerging remediation technologies for handling site remediation and restoration. At December 31, 2009, the Company had accrued obligations of $619 million for environmental remediation and restoration costs, including $80 million for the remediation of Superfund sites.
26
Midland Off-Site Environmental Matters
On June 12, 2003, the Michigan Department of Natural Resources and Environment (MDNRE, formerly the Michigan Department of Environmental Quality or MDEQ) issued a Hazardous Waste Operating License (the License) to the Companys Midland, Michigan manufacturing site (the Midland site), which included provisions requiring the Company to conduct an investigation to determine the nature and extent of off-site contamination in the City of Midland soils; the Tittabawassee River and Saginaw River sediment and floodplain soils; and the Saginaw Bay; and, if necessary, undertake remedial action.
City of Midland
Matters related to the City of Midland remain under the primary oversight of the State of Michigan (the State) under the License, and the Company and the State are in ongoing discussions regarding the implementation of the requirements of the License.
Tittabawassee and Saginaw Rivers, Saginaw Bay
The Company, the U.S. Environmental Protection Agency (EPA) and the State entered into an administrative order on consent (AOC), effective January 21, 2010, that requires the Company to conduct a remedial investigation, a feasibility study and a remedial design for the Tittabawassee River, the Saginaw River and the Saginaw Bay, and pay the oversight costs of the EPA and the State under the authority of the Comprehensive Environmental Response, Compensation, and Liability Act (CERCLA). These actions, to be conducted under the lead oversight of the EPA, will build upon the investigative work completed under the State Resource Conservation Recovery Act (RCRA) program from 2005 through 2009. The Tittabawassee River, beginning at the Midland Site and extending down to the first six miles of the Saginaw River, are designated as the first Operable Unit for purposes of conducting the remedial investigation, feasibility study and remedial design work. This work will be performed in a largely upriver to downriver sequence for eight geographic segments of the Tittabawassee and upper Saginaw Rivers. The remainder of the Saginaw River and the Saginaw Bay are designated as a second Operable Unit and the work associated with that unit may also be geographically segmented. The AOC does not obligate the Company to perform removal or remedial action; that action can only be required by a separate order.
Alternative Dispute Resolution Process
The Company; the EPA; the U.S. Department of Justice; and the natural resource damage trustees (the Michigan Office of the Attorney General; the MDNRE; the U.S. Fish and Wildlife Service; the U.S. Bureau of Indian Affairs and the Saginaw-Chippewa tribe), have been engaged in negotiations to seek to resolve potential governmental claims against the Company related to historical off-site contamination associated with the City of Midland, the Tittabawassee and Saginaw Rivers and the Saginaw Bay. The Company and the governmental parties started meeting in the fall of 2005 and entered into a Confidentiality Agreement in December 2005. The Company continues to conduct negotiations under the Federal Alternative Dispute Resolution Act with all of the governmental parties, except the EPA which withdrew from the alternative dispute resolution process on September 12, 2007.
On September 28, 2007, the Company and the natural resource damage trustees entered into a Funding and Participation Agreement that addressed the Companys payment of past costs incurred by the natural resource damage trustees, payment of the costs of a trustee coordinator and a process to review additional cooperative studies that the Company might agree to fund or conduct with the natural resource damage trustees. On March 18, 2008, the Company and the natural resource damage trustees entered into a Memorandum of Understanding to provide a mechanism for the Company to fund cooperative studies related to the assessment of natural resource damages. On April 7, 2008, the natural resource damage trustees released their Natural Resource Damage Assessment Plan for the Tittabawassee River System Assessment Area.
At September 30, 2010, the accrual for these off-site matters was $27 million (included in the total accrued obligation of $594 million at September 30, 2010). At December 31, 2009, the Company had an accrual for these off-site matters of $25 million (included in the total accrued obligation of $619 million).
27
Asbestos-Related Matters of Union Carbide Corporation
Union Carbide Corporation (Union Carbide), a wholly owned subsidiary of the Company, is and has been involved in a large number of asbestos-related suits filed primarily in state courts during the past three decades. These suits principally allege personal injury resulting from exposure to asbestos-containing products and frequently seek both actual and punitive damages. The alleged claims primarily relate to products that Union Carbide sold in the past, alleged exposure to asbestos-containing products located on Union Carbides premises, and Union Carbides responsibility for asbestos suits filed against a former Union Carbide subsidiary, Amchem Products, Inc. (Amchem). In many cases, plaintiffs are unable to demonstrate that they have suffered any compensable loss as a result of such exposure, or that injuries incurred in fact resulted from exposure to Union Carbides products.
Influenced by the bankruptcy filings of numerous defendants in asbestos-related litigation and the prospects of various forms of state and national legislative reform, the rate at which plaintiffs filed asbestos-related suits against various companies, including Union Carbide and Amchem, increased in 2001, 2002 and the first half of 2003. Since then, the rate of filing has significantly abated. Union Carbide expects more asbestos-related suits to be filed against Union Carbide and Amchem in the future, and will aggressively defend or reasonably resolve, as appropriate, both pending and future claims.
Based on a study completed by Analysis, Research & Planning Corporation (ARPC) in January 2003, Union Carbide increased its December 31, 2002 asbestos-related liability for pending and future claims for the 15-year period ending in 2017 to $2.2 billion, excluding future defense and processing costs. Since then, Union Carbide has compared current asbestos claim and resolution activity to the results of the most recent ARPC study at each balance sheet date to determine whether the accrual continues to be appropriate. In addition, Union Carbide has requested ARPC to review Union Carbides historical asbestos claim and resolution activity each November since 2004 to determine the appropriateness of updating the most recent ARPC study.
In November 2008, Union Carbide requested ARPC to review Union Carbides historical asbestos claim and resolution activity and determine the appropriateness of updating its then most recent study completed in December 2006. In response to that request, ARPC reviewed and analyzed data through October 31, 2008. The resulting study, completed by ARPC in December 2008, stated that the undiscounted cost of resolving pending and future asbestos-related claims against Union Carbide and Amchem, excluding future defense and processing costs, through 2023 was estimated to be between $952 million and $1.2 billion. As in its earlier studies, ARPC provided estimates for a longer period of time in its December 2008 study, but also reaffirmed its prior advice that forecasts for shorter periods of time are more accurate than those for longer periods of time.
In December 2008, based on ARPCs December 2008 study and Union Carbides own review of the asbestos claim and resolution activity, Union Carbide decreased its asbestos-related liability for pending and future claims to $952 million, which covered the 15-year period ending 2023, excluding future defense and processing costs. The reduction was $54 million and was shown as Asbestos-related credit in the consolidated statements of income. At December 31, 2008, the asbestos-related liability for pending and future claims was $934 million.
In November 2009, Union Carbide requested ARPC to review Union Carbides 2009 asbestos claim and resolution activity and determine the appropriateness of updating its December 2008 study. In response to that request, ARPC reviewed and analyzed data through October 31, 2009. In December 2009, ARPC stated that an update of its study would not provide a more likely estimate of future events than the estimate reflected in its study of the previous year and, therefore, the estimate in that study remained applicable. Based on Union Carbides own review of the asbestos claim and resolution activity and ARPCs response, Union Carbide determined that no change to the accrual was required. At December 31, 2009, Union Carbides asbestos-related liability for pending and future claims was $839 million. At December 31, 2009, approximately 23 percent of the recorded liability related to pending claims and approximately 77 percent related to future claims.
Based on Union Carbides review of 2010 activity, Union Carbide determined that no adjustment to the accrual was required at September 30, 2010. Union Carbides asbestos-related liability for pending and future claims was $800 million at September 30, 2010. Approximately 21 percent of the recorded liability related to pending claims and approximately 79 percent related to future claims.
28
At December 31, 2002, Union Carbide increased the receivable for insurance recoveries related to its asbestos liability to $1.35 billion, substantially exhausting its asbestos product liability coverage. The insurance receivable related to the asbestos liability was determined by Union Carbide after a thorough review of applicable insurance policies and the 1985 Wellington Agreement, to which Union Carbide and many of its liability insurers are signatory parties, as well as other insurance settlements, with due consideration given to applicable deductibles, retentions and policy limits, and taking into account the solvency and historical payment experience of various insurance carriers. The Wellington Agreement and other agreements with insurers are designed to facilitate an orderly resolution and collection of Union Carbides insurance policies and to resolve issues that the insurance carriers may raise.
In September 2003, Union Carbide filed a comprehensive insurance coverage case, now proceeding in the Supreme Court of the State of New York, County of New York, seeking to confirm its rights to insurance for various asbestos claims and to facilitate an orderly and timely collection of insurance proceeds (the Insurance Litigation). The Insurance Litigation was filed against insurers that are not signatories to the Wellington Agreement and/or do not otherwise have agreements in place with Union Carbide regarding their asbestos-related insurance coverage, in order to facilitate an orderly resolution and collection of such insurance policies and to resolve issues that the insurance carriers may raise. Since the filing of the case, Union Carbide has reached settlements with several of the carriers involved in the Insurance Litigation, including settlements reached with two significant carriers in the fourth quarter of 2009. The Insurance Litigation is ongoing.
Union Carbides receivable for insurance recoveries related to its asbestos liability was $84 million at September 30, 2010 and December 31, 2009. At September 30, 2010 and December 31, 2009, all of the receivable for insurance recoveries was related to insurers that are not signatories to the Wellington Agreement and/or do not otherwise have agreements in place regarding their asbestos-related insurance coverage.
In addition to the receivable for insurance recoveries related to its asbestos liability, Union Carbide had receivables for defense and resolution costs submitted to insurance carriers that have settlement agreements in place regarding their asbestos-related insurance coverage.
The following table summarizes Union Carbides receivables related to its asbestos-related liability:
Receivables for Asbestos-Related Costs In millions |
Sept. 30, 2010 |
Dec. 31, 2009 |
||||||
Receivables for defense costs carriers with settlement agreements |
$ 7 | $ 91 | ||||||
Receivables for resolution costs carriers with settlement agreements |
235 | 357 | ||||||
Receivables for insurance recoveries carriers without settlement agreements |
84 | 84 | ||||||
Total |
$326 | $532 |
Union Carbide expenses defense costs as incurred. The pretax impact for defense and resolution costs, net of insurance, was $22 million in the third quarter of 2010 ($20 million in the third quarter of 2009) and $58 million in the first nine months of 2010 ($40 million in the first nine months of 2009), and was reflected in Cost of sales.
After a review of its insurance policies, with due consideration given to applicable deductibles, retentions and policy limits, after taking into account the solvency and historical payment experience of various insurance carriers; existing insurance settlements; and the advice of outside counsel with respect to the applicable insurance coverage law relating to the terms and conditions of its insurance policies, Union Carbide continues to believe that its recorded receivable for insurance recoveries from all insurance carriers is probable of collection.
The amounts recorded by Union Carbide for the asbestos-related liability and related insurance receivable described above were based upon current, known facts. However, future events, such as the number of new claims to be filed and/or received each year, the average cost of disposing of each such claim, coverage issues among insurers, and the continuing solvency of various insurance companies, as well as the numerous uncertainties surrounding asbestos litigation in the United States, could cause the actual costs and insurance recoveries for Union Carbide to be higher or lower than those projected or those recorded.
29
Because of the uncertainties described above, Union Carbides management cannot estimate the full range of the cost of resolving pending and future asbestos-related claims facing Union Carbide and Amchem. Union Carbides management believes that it is reasonably possible that the cost of disposing of Union Carbides asbestos-related claims, including future defense costs, could have a material adverse impact on Union Carbides results of operations and cash flows for a particular period and on the consolidated financial position of Union Carbide.
It is the opinion of Dows management that it is reasonably possible that the cost of Union Carbide disposing of its asbestos-related claims, including future defense costs, could have a material adverse impact on the Companys results of operations and cash flows for a particular period and on the consolidated financial position of the Company.
Synthetic Rubber Industry Matters
In 2003, the U.S., Canadian and European competition authorities initiated separate investigations into alleged anticompetitive behavior by certain participants in the synthetic rubber industry. Certain subsidiaries of the Company (but as to the investigation in Europe only) have responded to requests for documents and are otherwise cooperating in the investigations.
On June 10, 2005, the Company received a Statement of Objections from the European Commission (the EC) stating that it believed that the Company and certain subsidiaries of the Company (the Dow Entities), together with other participants in the synthetic rubber industry, engaged in conduct in violation of European competition laws with respect to the butadiene rubber and emulsion styrene butadiene rubber businesses. In connection therewith, on November 29, 2006, the EC issued its decision alleging infringement of Article 81 of the Treaty of Rome and imposed a fine of Euro 64.575 million (approximately $85 million at that time) on the Dow Entities; several other companies were also named and fined. As a result, the Company recognized a loss contingency of $85 million related to the fine in the fourth quarter of 2006. The Company has appealed the ECs decision. On October 13, 2009, the Court of First Instance held a hearing on the appeal of all parties. Subsequent to the imposition of the fine, the Company and/or certain subsidiaries of the Company became named parties in various related U.S., United Kingdom and Italian civil actions. The U.S. matter was settled in March 2010 through a confidential settlement agreement which had an immaterial impact on the Company's consolidated financial statements.
Additionally, on March 10, 2007, the Company received a Statement of Objections from the EC stating that it believed that DuPont Dow Elastomers L.L.C. (DDE), a former 50:50 joint venture with E.I. du Pont de Nemours and Company (DuPont), together with other participants in the synthetic rubber industry, engaged in conduct in violation of European competition laws with respect to the polychloroprene business. This Statement of Objections specifically names the Company, in its capacity as a former joint venture owner of DDE. On December 5, 2007, the EC announced its decision to impose a fine on the Company, among others, in the amount of Euro 48.675 million (approximately $66 million). The Company previously transferred its joint venture ownership interest in DDE to DuPont in 2005, and DDE then changed its name to DuPont Performance Elastomers L.L.C. (DPE). In February 2008, DuPont, DPE and the Company each filed an appeal of the December 5, 2007 decision of the EC. Based on the Companys allocation agreement with DuPont, the Companys share of this fine, regardless of the outcome of the appeals, will not have a material adverse impact on the Companys consolidated financial statements.
Rohm and Haas Pension Plan Matters
In December 2005, a federal judge in the U.S. District Court for the Southern District of Indiana (the District Court) issued a decision granting a class of participants in the Rohm and Haas Pension Plan (the Rohm and Haas Plan) who had retired from Rohm and Haas, now a wholly owned subsidiary of the Company, and who elected to receive a lump sum benefit from the Rohm and Haas Plan, the right to a cost-of-living adjustment (COLA) as part of their retirement benefit. In August 2007, the Seventh Circuit Court of Appeals affirmed the District Courts decision, and in March 2008, the U.S. Supreme Court denied the Rohm and Haas Plans petition to review the Seventh Circuits decision. The case was returned to the District Court for further proceedings. In October 2008 and February 2009, the District Court issued rulings that have the effect of including in the class all Rohm and Haas retirees who received a lump sum distribution without a COLA from the Rohm and Haas Plan since January 1976. These rulings are subject to appeal, and the District Court has not yet determined the amount of the COLA benefits that may be due to the class participants. The Rohm and Haas Plan and the plaintiffs entered into a settlement agreement which was preliminarily approved by the District Court on November 24, 2009. In addition to settling the litigation with respect to the Rohm and Haas retirees, the settlement agreement provides for the amendment of the complaint and amendment to the Rohm and Haas Plan to include active
30
employees. Notices of the proposed settlement were provided to class members, and a hearing was held on March 12, 2010, to determine whether the settlement will be finally approved by the District Court. On April 12, 2010, the District Court issued a final order approving the settlement. An appeal of the final order by objectors to the settlement has been filed.
A pension liability associated with this matter of $185 million was recognized as part of the acquisition of Rohm and Haas on April 1, 2009. The liability, which was determined in accordance with the accounting guidance for contingencies, recognized the estimated impact of the above described judicial decisions on the long-term Rohm and Haas Plan obligations owed to the applicable Rohm and Haas retirees and active employees. At September 30, 2010 and December 31, 2009, the Company had a liability of $183 million associated with this matter.
Other Litigation Matters
In addition to breast implant, DBCP, environmental and synthetic rubber industry matters, the Company is party to a number of other claims and lawsuits arising out of the normal course of business with respect to commercial matters, including product liability, governmental regulation and other actions. Certain of these actions purport to be class actions and seek damages in very large amounts. All such claims are being contested. Dow has an active risk management program consisting of numerous insurance policies secured from many carriers at various times. These policies provide coverage that will be utilized to minimize the impact, if any, of the contingencies described above.
Summary
Except for the possible effect of Union Carbides asbestos-related liability described above, it is the opinion of the Companys management that the possibility is remote that the aggregate of all claims and lawsuits will have a material adverse impact on the results of operations, financial condition and cash flows of the Company.
Purchase Commitments
The Company has numerous agreements for the purchase of ethylene-related products globally. The purchase prices are determined primarily on a cost-plus basis. Total purchases under these agreements were $784 million in 2009, $1,502 million in 2008 and $1,624 million in 2007. The Companys take-or-pay commitments associated with these agreements at December 31, 2009 are included in the table below.
The Company also has various commitments for take-or-pay and throughput agreements. Such commitments are at prices not in excess of current market prices. The terms of all but two of these agreements extend from one to 25 years. One agreement has terms extending to 35 years and another has terms extending to 80 years. The determinable future commitments for these agreements are included for 10 years in the following table which presents the fixed and determinable portion of obligations under the Companys purchase commitments at December 31, 2009:
Fixed and Determinable Portion of Take-or-Pay and Throughput Obligations at December 31, 2009 In millions |
||||
2010 |
$ | 2,845 | ||
2011 |
2,655 | |||
2012 |
1,716 | |||
2013 |
1,088 | |||
2014 |
944 | |||
2015 and beyond |
5,969 | |||
Total |
$ | 15,217 |
In addition, in the second quarter of 2010, the Company entered into two new five-year contracts for the purchase of ethylene-related products beginning in 2010. At September 30, 2010, the fixed and determinable portion of the take-or-pay commitment associated with these new contracts was $142 million in 2010, $203 million in 2011, $211 million in 2012, $224 million in 2013 and $237 million in 2014.
In addition to the take-or-pay obligations at December 31, 2009, the Company had outstanding commitments which ranged from one to seven years for steam, electrical power, materials, property and other items used in the normal course of business of approximately $48 million. Such commitments were at prices not in excess of current market prices.
31
Guarantees
The Company provides a variety of guarantees as described more fully in the following sections.
Guarantees
Guarantees arise during the ordinary course of business from relationships with customers and nonconsolidated affiliates when the Company undertakes an obligation to guarantee the performance of others (via delivery of cash or other assets) if specified triggering events occur. With guarantees, such as commercial or financial contracts, non-performance by the guaranteed party triggers the obligation of the Company to make payments to the beneficiary of the guarantee. The majority of the Companys guarantees relate to debt of nonconsolidated affiliates, which have expiration dates ranging from less than one year to ten years, and trade financing transactions in Latin America, which typically expire within one year of their inception. The Companys current expectation is that future payment or performance related to the non-performance of others is considered unlikely.
Residual Value Guarantees
The Company provides guarantees related to leased assets specifying the residual value that will be available to the lessor at lease termination through sale of the assets to the lessee or third parties.
The following tables provide a summary of the final expiration, maximum future payments and recorded liability reflected in the consolidated balance sheets for each type of guarantee:
Guarantees at September 30, 2010 In millions |
Final Expiration |
Maximum Future Payments |
Recorded Liability |
|||||||
Guarantees |
2020 | $266 | $ | 51 | ||||||
Residual value guarantees (1) |
2017 | 352 | 5 | |||||||
Total guarantees |
$618 | $ | 56 |
(1) | Does not include residual value guarantees of the Companys variable interest in an owner trust which was consolidated in the first quarter of 2010, with the adoption of ASU 2009-17 (see Notes B and L). |
Guarantees at December 31, 2009 In millions |
Final Expiration |
Maximum Future Payments |
Recorded Liability |
|||||||
Guarantees |
2020 | $ 358 | $ | 52 | ||||||
Residual value guarantees |
2014 | 695 | 5 | |||||||
Total guarantees |
$1,053 | $ | 57 |
Asset Retirement Obligations
The Company has recognized asset retirement obligations for the following activities: demolition and remediation activities at manufacturing sites in the United States, Canada, Brazil and Europe; capping activities at landfill sites in the United States, Canada, Brazil and Europe; and asbestos encapsulation as a result of planned demolition and remediation activities at manufacturing and administrative sites in the United States, Canada, Brazil and Europe.
The aggregate carrying amount of asset retirement obligations recognized by the Company was $98 million at September 30, 2010 and $101 million at December 31, 2009. The discount rate used to calculate the Companys asset retirement obligation was 2.45 percent. These obligations are included in the consolidated balance sheets as Other noncurrent obligations.
The Company has not recognized conditional asset retirement obligations for which a fair value cannot be reasonably estimated in its consolidated financial statements. It is the opinion of the Companys management that the possibility is remote that such conditional asset retirement obligations, when estimable, will have a material adverse impact on the Companys consolidated financial statements based on current costs.
32
NOTE K TRANSFERS OF FINANCIAL ASSETS
On January 1, 2010, the Company adopted ASU 2009-16, Transfers and Servicing (Topic 860): Accounting for Transfers of Financial Assets. This ASU is intended to improve the information provided in financial statements concerning transfers of financial assets, including the effects of transfers on financial position, financial performance and cash flows, and any continuing involvement of the transferor with the transferred financial assets. The Company evaluated the impact of adopting the guidance and the terms and conditions in place at January 1, 2010 and determined that certain sales of accounts receivable would be classified as secured borrowings. Under the Companys sale of accounts receivable arrangements, $915 million was outstanding at January 1, 2010. The maximum amount of receivables available for participation in these programs was $1,939 million at January 1, 2010.
In January 2010, the Company terminated the North American arrangement and replaced it with a new arrangement that qualified for treatment as a sale under ASU 2009-16. The arrangement related to $294 million of the $915 million outstanding at January 1, 2010 and $1,100 million of the $1,939 million maximum participation.
In June 2010, the Company terminated the European arrangement and replaced it with a new arrangement that qualified for treatment as a sale under ASU 2009-16. The arrangement related to $584 million of the $915 million outstanding at January 1, 2010 and $721 million of the $1,939 million maximum participation.
Sale of Trade Accounts Receivable in North America
In January 2010, the Company terminated its previous facilities used in North America for the transfers of trade accounts receivable by entering into an agreement to repurchase the outstanding receivables for $264 million and replacing it with a new arrangement. During the nine-month period ended September 30, 2010, under the new arrangement, the Company sold the trade accounts receivable of select North America entities on a revolving basis to certain multi-seller commercial paper conduit entities. The Company maintains servicing responsibilities and the related costs are insignificant. The proceeds received are comprised of cash and interests in specified assets (the receivables sold by the Company) of the conduits that entitle the Company to the residual cash flows of such specified assets in the conduits after the commercial paper has been repaid. Neither the conduits nor the investors in those entities have recourse to other assets of the Company in the event of nonpayment by the debtors.
During the three-month period ended September 30, 2010, the Company recognized a loss of $5 million on the sale of these receivables ($14 million for the nine-month period ended September 30, 2010), which is classified as Interest expense and amortization of debt discount in the consolidated statements of income. The Company classifies its interests in the conduits as Accounts and notes receivable Other on the consolidated balance sheets and those interests are carried at fair value. Fair value of the interests is determined by calculating the expected amount of cash to be received and is based on unobservable inputs (a Level 3 measurement). The key input in the valuation is percentage of anticipated credit losses, which was 1.44 percent, in the portfolio of receivables sold that have not yet been collected. Given the short-term nature of the underlying receivables, discount rates and prepayments are not factors in determining the fair value of the interests. At September 30, 2010, the carrying value of the interests held was $1,160 million, which is the Companys maximum exposure to loss related to the receivables sold.
The sensitivity of the fair value of the interests held to hypothetical adverse changes in the anticipated credit losses are as follows (amounts shown are the corresponding hypothetical decreases in the carrying value of the interests):
Impact to Carrying Value In millions |
||||
10% adverse change |
$ | 2 | ||
20% adverse change |
$ | 4 |
Following is an analysis of certain cash flows between the Company and the North American conduits:
Cash Proceeds In millions |
Nine Months Ended Sept. 30, 2010 |
|||
Sale of receivables |
$264 | |||
Collections reinvested in revolving receivables |
$12,611 | |||
Interests in conduits (1) |
$810 |
(1) | Presented in operating activities in the consolidated statements of cash flows. |
33
Delinquencies on the sold receivables that were still outstanding at September 30, 2010 were $131 million. Trade accounts receivable outstanding and derecognized from the Companys consolidated balance sheet at September 30, 2010 were $1,980 million. Credit losses, net of any recoveries, on receivables sold during the nine-month period ended September 30, 2010 were $2 million.
Sale of Trade Accounts Receivable in Europe
In June 2010, the Company terminated its previous facility used in Europe for the transfers of trade accounts receivable by entering into an agreement to repurchase the outstanding receivables for $11 million and replacing it with a new arrangement. Since June 2010, under the new arrangement, the Company sold qualifying trade accounts receivable of select European entities on a revolving basis to certain multi-seller commercial paper conduit entities. The Company maintains servicing responsibilities and the related costs are insignificant. The proceeds received are comprised of cash and interests in specified assets (the receivables sold by the Company) of the conduits that entitle the Company to the residual cash flows of such specified assets in the conduits after the commercial paper has been repaid. Neither the conduits nor the investors in those entities have recourse to other assets of the Company in the event of nonpayment by the debtors.
During the three-month period ended September 30, 2010, the Company recognized a loss of $3 million on the sale of these receivables ($4 million from the June 2010 inception of the new arrangement through September 30, 2010), which is classified as Interest expense and amortization of debt discount in the consolidated statements of income. The Company classifies its interests in the conduits as Accounts and notes receivable Other on the consolidated balance sheets and those interests are carried at fair value. Fair value of the interests is determined by calculating the expected amount of cash to be received and is based on unobservable inputs (a Level 3 measurement). The key input in the valuation is percentage of anticipated credit losses, which was zero, in the portfolio of receivables sold that have not yet been collected. Given the short-term nature of the underlying receivables, discount rates and prepayments are not factors in determining the fair value of the interests. At September 30, 2010, the carrying value of the interests held was $152 million, which is the Companys maximum exposure to loss related to the receivables sold.
Following is an analysis of certain cash flows between the Company and the European conduits:
Cash Proceeds In millions |
Nine Months Ended Sept. 30, 2010 |
|||
Sale of receivables |
$582 | |||
Collections reinvested in revolving receivables |
$2,018 | |||
Interests in conduits (1) |
$8 |
(1) | Presented in operating activities in the consolidated statements of cash flows. |
Delinquencies on the sold receivables still outstanding at September 30, 2010 were $19 million. Trade accounts receivable outstanding and derecognized from the Companys consolidated balance sheet at September 30, 2010 were $399 million. There were no credit losses on receivables sold since June 2010.
Sale of Trade Accounts Receivable in Asia Pacific
During the nine-month period ended September 30, 2010, the Company sold a participating interest in trade accounts receivable of select Asia Pacific entities for which the Company maintains servicing responsibilities and the related costs are insignificant. The third-party holders of the participating interests do not have recourse to the Companys assets in the event of nonpayment by the debtors.
During the three- and nine-month periods ended September 30, 2010, the Company recognized a loss of less than $1 million on the sale of the participating interests in the receivables. The Company receives cash upon the sale of the participating interests in the receivables.
34
Following is an analysis of certain cash flows between the Company and the third-party holders of the participating interests:
Cash Proceeds In millions |
Nine Months Ended Sept. 30, 2010 |
|||
Sale of participating interests |
$163 | |||
Collections reinvested in revolving receivables |
$145 |
Following is additional information related to the sale of participating interests in the receivables under this facility:
Trade Accounts Receivable In millions |
Sept. 30, 2010 | |||
Derecognized from the consolidated balance sheet |
$ 28 | |||
Outstanding in the consolidated balance sheet |
239 | |||
Total accounts receivable in select Asia Pacific entities |
$267 |
Credit losses, net of any recoveries, on receivables relating to the participating interests sold during the nine-month period ended September 30, 2010 and delinquencies on the outstanding receivables at September 30, 2010 related to the participating interests sold were zero.
NOTE L VARIABLE INTEREST ENTITIES
On January 1, 2010, the Company adopted ASU 2009-17, Consolidations (Topic 810): Improvements to Financial Reporting by Enterprises Involved with Variable Interest Entities. ASU 2009-17 amends the consolidation guidance applicable to variable interest entities (VIEs) and requires additional disclosures concerning an enterprises continuing involvement with VIEs. The Company evaluated the impact of this guidance and determined that the adoption resulted in the January 1, 2010 consolidation of two additional joint ventures, an owner trust and an entity that is used to monetize accounts receivable. The Company elected prospective application of this guidance at adoption.
The following table summarizes the carrying amount of the assets and liabilities of the two additional joint ventures and the owner trust entity included in the Companys consolidated balance sheet at January 1, 2010.
Assets and Liabilities of Newly Consolidated VIEs Included in the Consolidated Balance Sheet In millions |
Jan. 1, 2010 | |||
Current assets |
$ 37 | |||
Property |
209 | |||
Other noncurrent assets |
3 | |||
Total assets |
$249 | |||
Current liabilities |
$ 76 | |||
Long-term debt |
346 | |||
Total liabilities |
$422 |
The carrying amounts of assets and liabilities pertaining to the entity used to monetize accounts receivables, included in the Companys consolidated balance sheet at January 1, 2010, were current assets of $817 million (including $436 million of restricted cash) and current liabilities of $589 million.
Consolidated Variable Interest Entities
The Company holds a variable interest in four joint ventures for which the Company is the primary beneficiary. Three of the joint ventures are development stage enterprises, which will produce propylene oxide and hydrogen peroxide and provide terminal services in Thailand. The Companys variable interest in these joint ventures relates to cost-plus arrangements between the joint venture and the Company, involving the majority of the output on take-or-pay terms and ensuring a guaranteed return to the joint ventures. At September 30, 2010, the Company provided guarantees with a maximum exposure of $770 million on the construction-related debt of these joint ventures.
35
The other joint venture was acquired through the acquisition of Rohm and Haas on April 1, 2009. This joint venture manufactures products in Japan for the semiconductor industry. Each joint venture partner holds several equivalent variable interests, with the exception of a royalty agreement held exclusively between the joint venture and the Company. In addition, the entire output of the joint venture is sold to the Company for resale to third-party customers.
The Company holds a variable interest in an owner trust, for which the Company is the primary beneficiary. The owner trust leases an ethylene facility in The Netherlands to the Company, whereby substantially all of the rights and obligations of ownership are transferred to the Company. The Companys variable interest in the owner trust relates to a residual value guarantee provided to the owner trust. Upon expiration of the lease, which matures in 2014, the Company may purchase the facility for an amount based on a fair market value determination. At September 30, 2010, the Company had provided to the owner trust a residual value guarantee of $363 million, which represents the Companys maximum exposure to loss under the lease.
As the primary beneficiary of these VIEs, the entities assets, liabilities and results of operations are included in the Companys consolidated financial statements. The other equity holders interests are reflected in Net income attributable to noncontrolling interests in the consolidated statements of income and Noncontrolling interests in the consolidated balance sheets. The following table summarizes the carrying amounts of the entities assets and liabilities included in the Companys consolidated balance sheets at September 30, 2010 and December 31, 2009:
Assets and Liabilities of Consolidated VIEs In millions |
Sept. 30, 2010 |
Dec. 31, 2009 |
||||||
Current assets (restricted 2010: $163) |
$ 163 | $102 | ||||||
Property (restricted 2010: $1,114) |
1,114 | 455 | ||||||
Other noncurrent assets (restricted 2010: $120) |
120 | 81 | ||||||
Total assets |
$1,397 | $638 | ||||||
Current liabilities (nonrecourse 2010: $182) |
$ 726 | $183 | ||||||
Long-term debt (nonrecourse 2010: $139) |
485 | 125 | ||||||
Other noncurrent liabilities (nonrecourse 2010: $63) |
63 | 43 | ||||||
Total liabilities |
$1,274 | $351 |
The Company holds a variable interest in an entity created in June 2010, used to monetize accounts receivable originated by several European subsidiaries. The Company is the primary beneficiary of this entity as a result of holding subordinated notes while maintaining servicing responsibilities for the accounts receivable. The carrying amounts of assets and liabilities pertaining to this entity, included in the Companys consolidated balance sheet at September 30, 2010, were current assets of $153 million (zero restricted) and current liabilities of $1 million ($1 million nonrecourse). Prior to the creation of this entity, the Company held a variable interest in another entity that was also used to monetize accounts receivable originated by several European subsidiaries. That arrangement was terminated in June 2010. No gain or loss was recognized as a result of terminating the arrangement.
Amounts presented in the consolidated balance sheet and the table above as restricted assets or nonrecourse obligations relating to consolidated VIEs at September 30, 2010 are adjusted for intercompany eliminations, parental guarantees and residual value guarantees.
Nonconsolidated Variable Interest Entity
The Company holds a variable interest in a joint venture accounted for under the equity method of accounting, acquired through the acquisition of Rohm and Haas on April 1, 2009. The joint venture manufactures crude acrylic acid in the United States and Germany on behalf of the Company and the other joint venture partner. The variable interest relates to a cost-plus arrangement between the joint venture and each joint venture partner. The Company is not the primary beneficiary, as a majority of the joint ventures output is sold to the other joint venture partner, and therefore the entity is not consolidated. At September 30, 2010, the Companys investment in the joint venture was $143 million, classified as Investment in nonconsolidated affiliates in the consolidated balance sheet, representing the Companys maximum exposure to loss.
36
NOTE M PENSION PLANS AND OTHER POSTRETIREMENT BENEFITS
Net Periodic Benefit Cost for All Significant Plans | Three Months Ended | Nine Months Ended | ||||||||||||||
In millions | Sept. 30, 2010 |
Sept. 30, 2009 |
Sept. 30, 2010 |
Sept. 30, 2009 |
||||||||||||
Defined Benefit Pension Plans: |
||||||||||||||||
Service cost |
$ 76 | $ 70 | $ 232 | $ 198 | ||||||||||||
Interest cost |
272 | 281 | 821 | 799 | ||||||||||||
Expected return on plan assets |
(301) | (323) | (907) | (932) | ||||||||||||
Amortization of prior service cost |
7 | 8 | 21 | 24 | ||||||||||||
Amortization of net loss |
67 | 27 | 201 | 79 | ||||||||||||
Curtailment cost |
- | - | 8 | - | ||||||||||||
Net periodic benefit cost |
$ 121 | $ 63 | $ 376 | $ 168 | ||||||||||||
Other Postretirement Benefits: |
||||||||||||||||
Service cost |
$ 4 | $ 5 | $ 12 | $ 14 | ||||||||||||
Interest cost |
28 | 35 | 84 | 100 | ||||||||||||
Expected return on plan assets |
(3) | (4) | (9) | (12) | ||||||||||||
Amortization of prior service credit |
- | (1) | - | (3) | ||||||||||||
Curtailment cost |
- | - | 3 | - | ||||||||||||
Net periodic benefit cost |
$ 29 | $ 35 | $ 90 | $ 99 |
As a result of the divestiture of the Styron business unit on June 17, 2010, the Company recognized a curtailment loss of $11 million and improved the funded status (plan assets less benefit obligations) by $99 million due to settlements, remeasurements and curtailments in the second quarter of 2010 (see Note E).
The Companys funding policy is to contribute to its pension plans when pension laws and/or economics either require or encourage funding. In the nine-month period ended September 30, 2010, the Company contributed $177 million to its pension plans, including contributions to fund benefit payments for its non-qualified supplemental plans. The Company expects to contribute approximately $400 million to its pension plans in the fourth quarter of 2010.
NOTE N STOCK-BASED COMPENSATION
The Company grants stock-based compensation to employees under the Employees Stock Purchase Plan (ESPP) and the 1988 Award and Option Plan (the 1988 Plan) and to non-employee directors under the 2003 Non-Employee Directors Stock Incentive Plan. Most of the Companys stock-based compensation awards are granted in the first quarter of each year. Details for awards granted in the first quarter of 2010 are included in the following paragraphs. There was minimal grant activity in the second and third quarters of 2010.
During the first quarter of 2010, employees subscribed to the right to purchase 13.8 million shares with a weighted-average exercise price of $18.09 per share and a weighted-average fair value of $11.90 per share under the ESPP.
During the first quarter of 2010, the Company granted the following stock-based compensation awards to employees under the 1988 Plan:
| 8.5 million stock options with a weighted-average exercise price of $27.79 per share and a weighted-average fair value of $9.17 per share; |
| 4.3 million shares of deferred stock with a weighted-average fair value of $27.81 per share; and |
| 0.9 million shares of performance deferred stock with a weighted-average fair value of $27.79 per share. |
37
During the first quarter of 2010, the Company granted the following stock-based compensation awards to non-employee directors under the 2003 Non-Employee Directors Stock Incentive Plan:
| 38,940 shares of restricted stock with a weighted-average fair value of $30.00 per share. |
Total unrecognized compensation cost at September 30, 2010, including unrecognized cost related to the first quarter of 2010 activity, is provided in the following table:
Total Unrecognized Compensation Cost at September 30, 2010 | ||||||||
In millions | Unrecognized Compensation Cost |
Weighted-average Recognition Period |
||||||
ESPP purchase rights |
$11 | 0.13 year | ||||||
Unvested stock options |
$43 | 0.71 year | ||||||
Deferred stock awards |
$108 | 0.86 year | ||||||
Performance deferred stock awards |
$40 | 0.57 year |
At September 30, 2010, the total amount of unrecognized tax benefits was $315 million ($650 million at December 31, 2009), of which $293 million ($610 million at December 31, 2009) would impact the effective tax rate, if recognized. The reduction in 2010 was primarily due to settlements of uncertain tax positions with tax authorities.
The Company is currently under examination in a number of tax jurisdictions. It is reasonably possible that these examinations may be resolved within the next twelve months. As a result, it is reasonably possible that the total gross unrecognized tax benefits of the Company at September 30, 2010 will be reduced by approximately $51 million. The amount of settlement remains uncertain and it is reasonably possible that before settlement, the amount of gross unrecognized tax benefits may increase or decrease by approximately $30 million. The impact on the Companys results of operations is not expected to be material.
38
NOTE P EARNINGS PER SHARE CALCULATIONS
Net Income | Three Months Ended | Nine Months Ended | ||||||||||||||
In millions | Sept. 30, 2010 |
Sept. 30, 2009 |
Sept. 30, 2010 |
Sept. 30, 2009 |
||||||||||||
Income from continuing operations |
$597 | $799 | $1,808 | $388 | ||||||||||||
Income (loss) from discontinued operations, net of income taxes (benefit) |
- | (4) | - | 110 | ||||||||||||
Net loss (income) attributable to noncontrolling interests |
- | 1 | (9) | (22) | ||||||||||||
Net income attributable to The Dow Chemical Company |
$597 | $796 | $1,799 | $476 | ||||||||||||
Preferred stock dividends |
(85) | (85) | (255) | (227) | ||||||||||||
Net income available for common stockholders |
$512 | $711 | $1,544 | $249 | ||||||||||||
Earnings Per Share Calculations - Basic | Three Months Ended | Nine Months Ended | ||||||||||||||
Dollars per share | Sept. 30, 2010 |
Sept. 30, 2009 |
Sept. 30, 2010 |
Sept. 30, 2009 |
||||||||||||
Income from continuing operations |
$0.53 | $0.72 | $1.61 | $0.38 | ||||||||||||
Income (loss) from discontinued operations, net of income taxes (benefit) |
- | (0.01) | - | 0.11 | ||||||||||||
Net loss (income) attributable to noncontrolling interests |